Introduction {#Sec1}
============

Osteoarthritis (OA), the most common form of arthritis, is a major cause of chronic pain and disability. OA confers a huge burden on both individuals and health economies \[[@CR1], [@CR2]\]. There are currently no licensed disease-modifying osteoarthritis drugs (DMOADs) but ideally these should both inhibit structural progression and improve symptoms and/or function \[[@CR3], [@CR4]\]. While hyaline cartilage loss is the hallmark pathology, clinical OA usually involves multiple tissues. Describing the relationships of these tissues with structural progression and symptoms may identify potential tissue targets.

The subchondral bone in particular is intimately associated with hyaline cartilage and therefore a tissue of great potential interest. Conventional radiographs are known to be relatively insensitive to the structural features of OA \[[@CR5]\], in part because they do not assess three-dimensional (3D) bone structure \[[@CR6]\]. A number of non-conventional radiographic imaging modalities accurately demonstrate in vivo subchondral bone pathological changes, including magnetic resonance imaging (MRI), computed tomography (CT), dual-energy x-ray absorptiometry (DXA), scintigraphy and positron emission tomography (PET) \[[@CR5], [@CR7]--[@CR13]\]. Hunter and colleagues found a moderate association between bone marrow lesions (BMLs), structural progression and longitudinal change in pain in a systematic review focused on MRI biomarkers and knee OA \[[@CR7]\]. In another systematic review Kloppenburg and colleagues examined associations between MRI features and knee pain, but not structural pathology \[[@CR14]\].

We therefore wished to comprehensively review the literature on subchondral bone structure assessed with all non-conventional radiographic imaging modalities, examining the common sites of peripheral OA and describing the relationships between imaging-detected subchondral bone features and joint replacement, structural progression and pain.

Methods {#Sec2}
=======

Systematic literature search {#Sec3}
----------------------------

A systematic literature search of Medline (from 1950), EMBASE (from 1980) and the Cochrane library databases until September 2014 was performed. A full description of the search terms used is recorded in Additional file [1](#MOESM1){ref-type="media"}: Table S1. An abbreviation of the full search terms used was 'knee, hip, hand, foot and ankle' and 'osteoarthritis' and 'subchondral bone' manifestations of OA ('bone marrow lesion', 'osteophyte', 'bone cyst', 'bone area', 'bone shape', 'bone attrition', bone morphometry and mineral density) and 'MRI' or 'CT' or 'DXA' or 'scintigraphy' or 'PET'. The search term 'bone shape' was not restricted to non-conventional radiographic imaging. The final search was restricted to humans. There was no language restriction and abstracts were not excluded. Exclusion criteria are listed in Fig. [1](#Fig1){ref-type="fig"}. Any analysis of fewer than 20 patients with confirmed OA was excluded to remove papers at risk of study imprecision. The inclusion criteria were in vivo observational studies of a human population with clinical and/or radiographic OA, which included an imaging description of the adjacent subchondral bone pathology to the osteoarthritic joint and the relationship of this with pain, structural progression or joint replacement. Analyses describing the relationship between OA bone manifestations and structural severity (cross-sectional) or progression (prospective cohorts) in populations without clinical and radiographic OA were included to incorporate early structural features of joint degeneration. The outcome measures of structural severity or progression included cartilage defects, cartilage thickness, cartilage volume, denuded subchondral bone, Kellgren-Lawrence (KL)grade, joint space width and joint space narrowing. Other outcome measures included joint replacement and any pain measures.Fig. 1Search strategy results and article exclusion. \*Two articles included both cross-sectional and longitudinal data. Longitudinal data included 16 case--control studies and 55 cohort studies

The articles identified by the preliminary search were screened by two reviewers (DH, AB) for relevance and for references not identified by the preliminary search, although no additional citations were found. Discordance in opinion was resolved by a third reviewer (SK). We applied the methods for reporting meta-analyses of observational studies in epidemiology that are recommended by the Cochrane collaboration \[[@CR15], [@CR16]\].

Data extraction {#Sec4}
---------------

Data extraction was performed by two reviewers (DH, AB) as described in the Supplementary methods 'data extraction' (see Additional file [1](#MOESM1){ref-type="media"}).

Quality assessment {#Sec5}
------------------

The quality of each observational study was independently assessed by two reviewers (TC, AB), as described in Supplementary methods 'Quality assessment' (see Additional file [1](#MOESM1){ref-type="media"}).

Best evidence synthesis {#Sec6}
-----------------------

Statistical pooling of the data was considered inappropriate in light of the heterogeneous study populations, methodological quality and bone feature or outcome measurements for OA. Therefore a qualitative summary of the evidence for each bone feature (e.g., BML) and its association with pain or structural progression and joint replacement was provided based on the study design, adequacy of adjustment for confounders (age, body mass index and gender) and quality score as described in the Supplementary methods 'Best evidence synthesis' (see Additional file [1](#MOESM1){ref-type="media"}).

Studies that investigated the association between multiple bone features and OA pain or structural progression outcomes were considered as a single study for each bone feature. Included studies that established significant correlation between bone and pain, structural progression or joint replacement were described as positive (+) or negative (−) accordingly. If no association or inconclusive findings were described this was reported as no association (NA) or no conclusion (NC) respectively.

Results {#Sec7}
=======

Systematic literature search and selection {#Sec8}
------------------------------------------

The Preferred reporting items for systematic reviews and meta-analyses (PRISMA) diagram in Fig. [1](#Fig1){ref-type="fig"} describes the literature flow. Following exclusion of duplicates and triplicates, 2,456 articles met the search criteria. After applying inclusion/exclusion criteria, 139 articles were included for data extraction and quality scoring. In total, 71 papers provided longitudinal data (55 cohorts, 16 case−controls), 70 provided cross-sectional data, and two papers provided both.

Data extraction from selected studies {#Sec9}
-------------------------------------

In only 12 studies did the mean age fall below 50 years \[[@CR17]--[@CR29]\]. Most (n = 93) described both genders; 2 studies included men only \[[@CR27], [@CR30]\], 14 studies included female individuals only \[[@CR22], [@CR28], [@CR29], [@CR31]--[@CR41]\] and there was an undisclosed gender ratio in 6 \[[@CR42]--[@CR50]\]. Knee OA was defined using clinical and radiographic criteria and is described in Additional file [1](#MOESM1){ref-type="media"}: Table S6. Radiographic OA was invariably defined as KL grade ≥2 or any radiographic OA abnormality from the Altman atlas \[[@CR51]\]. Individual pain or structural progression measures were examined in 88 studies; 52 studies examined multiple features. Subchondral bone was analyzed with MRI in 113 articles, DXA in 8 \[[@CR30]--[@CR32], [@CR42], [@CR52]--[@CR55]\], CT in 4 \[[@CR33], [@CR40], [@CR56], [@CR57]\], and scintigraphy in 8 \[[@CR24], [@CR37], [@CR38], [@CR58]--[@CR62]\], and no articles using PET met the inclusion criteria. Included articles described 116 knee, 15 hip, 6 hand and 2 ankle studies. Of these studies 13 described structural associations without clinical or radiographic OA \[[@CR18], [@CR19], [@CR23], [@CR25], [@CR26], [@CR35], [@CR63]--[@CR69]\]. There were no articles on studies of the foot that met the inclusion criteria.

Quality assessment of studies {#Sec10}
-----------------------------

Concordance of opinion in quality scoring was observed in 2,040 (89 %) of the 2,242 scoring items assessed, which are recorded in Additional file [1](#MOESM1){ref-type="media"}: Tables S3-S5. The majority of discordant scoring was for study design (criteria 17) and data presentation (criteria 18). Quality scores were converted to percentages of the maximum scores for each class of paper. The mean (range) quality score was 59 % (29--79), 54 % (22--83) and 59 % (47--76) for cross-sectional, cohort and case--control studies, respectively.

Relationship between knee bone feature and structural progression {#Sec11}
-----------------------------------------------------------------

The association of bone features with structural progression and joint replacement are described in Tables [1](#Tab1){ref-type="table"} and [5](#Tab5){ref-type="table"}.Table 1Knee structural associations by feature and quality gradeAuthorFeature (method)Structural progression outcomeAdjustment for confoundersAssociation (magnitude) crudeAssociation (magnitude) adjustedAssociationQuality (score %)MRI bone marrow lesion - cohortsFelson 2003 \[[@CR70]\]Baseline presence of BML in medial or lateral TFJ (C)OARSI JSN grade progression of TFJ (L)Age, sex, and BMINROR 6.5,+High (83)95 % CI 3.0 to 14.0Dore 2010 \[[@CR124]\]Baseline semi-quantitative MRI BML size (C) TFJIncident TKR over 5 years (L)Age, sex, BMI, knee baseline pain, leg strength, cartilage defects, tibial bone area, ROAOR (95 % CI)OR (95 % CI)+High (64)2.04 (1.55 to 2.69)2.10 (1.13 to 3.90)*p* \<0.01*p* = 0.019Driban 2013 \[[@CR72]\]Knee baseline BML volume (C)48-month change in OARSI JSN grade (L)Age, sex, BMINRBaseline BML volume+High (61)OR 1.27, 95 % CI 1.11 to 1.46BML volume 48 month change (L) (TFJ)(TFJ)BML volume regressionOR 3.36, 95 % CI 1.55 to 7.28Davies-Tuck 2010 \[[@CR67]\]Incident BML (new BML after 2 years with no BMLs at baseline) MRI TFJ (L)Progression in semi-quantitative MRI cartilage defects score after 2 years. TFJ (L)Age, gender, BMI, baseline cartilage volumeOR (95 % CI)OR (95 % CI)+High (61)Medial TFJMedial TFJAssociation in the lateral TFJ and a trend in the medial TFJ1.86 (0.70 to 4.93) *p* = 0.212.63 (0.93 to 7.44) *p* = 0.07Lateral TFJLateral TFJ3.0 (1.01 to 8.93) *p* = 0.053.13 (1.01 to 9.68) *p* = 0.05Hochberg 2014 \[[@CR44]\]Semi-quantitative MRI baseline femoral condyle BML size (C)Incident TKR over 6 years (L)Age, gender, BMI, race, marital status, depressive symptoms, quality of life, mechanical pain, KL grade, clinical effusion.Medial TFJMedial TFJ+High (61)*p* \<0.0001*p* = 0.02Raynauld 2011 \[[@CR75]\]Baseline semi-quantitative BML score (C) TFJIncidence of TKR over 3 years (L)Age, sex, BMI, JSW, WOMAC,NROR (95% CI)+High (61)BML medial plateau1.81 (1.08 to 2.03)*p* = 0.025Raynauld 2013 \[[@CR74]\]Baseline semi-quantitative BML WORMS score (C) medial TFJIncident TKR (L) 4 year follow upAge, BMI, gender WOMAC, CRPNRTKR incidence+High (61)OR (95 % CI) 2.107 (1.26 to 3.54) *p* = 0.005 time to TKR incidence hazard ratio (95% CI) 2.13 (1.38 to 3.30) *p* = 0.001Time to TKR (L)Crema 2014 \[[@CR71]\]MRI BML (semi-quantitative)Cartilage loss (semi-quantitative)Age, gender, BMINR*β* = 0.37 to 0.64 *p* \<0.001+High (56)(C) all regions(L) (all regions)Guermazi 2014 Abstract \[[@CR73]\]Baseline semi-quantitative BML score WORMS (C)Cartilage thickness loss over 30 months (L)Age, sex, body mass index, and anatomical alignment axis (degrees)NRCombined BML score in the medial and lateral TFJ compartment+High (56)OR 1.9, 95 % CI 1.1 to 3.3Scher 2008 \[[@CR87]\]Presence of any baseline semi-quantitative MRI BMLs (C)Incident TKR (L) over 3 yearsAgeNROR (95 % CI)+High (56)8.95 (1.49 to 53.68)*p* = 0.02Sowers 2011 \[[@CR28]\]Semi-quantitative MRI BML, size in TFJ (C)Progression in KL gradeNil*R* (95 % CI) medial tibia \~ 0.46 (0.35 to 0.55)NR+Low (53)(11-year follow up) (L)Lateral tibia \~0.23 (0.13 to 0.33)Kothari 2010 \[[@CR82]\]Semi-quantitative baseline MRI BML, (WORMS) (C) TFJSemi-quantitative cartilage defect score change over 2 years (WORMS) (L) TFJ.Age, sex, BMI, other bone lesionsOR 4.04,OR 3.75,+Low (50)95 % CI 2.25 to 7.2695 % CI 1.59 to 8.82Raynauld 2008 \[[@CR85]\]Change in BML size (mm) at 24 months in medial TFJ (L)Medial cartilage volume (L) at 24 months in medial TFJAge, gender, BMI, meniscal extrusion and tear, pain and bone lesions at baselineNRChange in BML size with femoral cartilage volume loss-Low (50)Larger medial BML size means more cartilage loss in medial compartment*β* = −0.31standard error (0.08)*p* = 0.0004Roemer 2009 \[[@CR90]\]Change in MRI semi-quantitative BML size (WORMS) (L) TFJ and PFJProgression in semi-quantitative cartilage defects in (WORMS) over 30 months (L) TFJ and PFJAge, sex, BMI, baseline KL gradeNROR (95 % CI)+Low (50)Incident BML OR 3.5 (2.1 to 5.9)Progression of BML 2.8 (1.5 to 3.2)Resolution of BML OR 0.9 (0.5 to 1.6)Stable BML OR 1.0 (reference)Dore 2010 \[[@CR76]\]Baseline semi-quantitative BML severity (C) (medial and lateral TFJ)Ipsi-compartmental annual Cartilage volume loss (L)Age, sex, BMI, meniscal damageNRBaseline-Low (50)BML severityBigger BML means bigger volume loss*β* = −22.1 to −42.0, for all regions(*p* \<0.05)Parsons 2014 Abstract \[[@CR83]\]Baseline semi-quantitative BML score (C)Annual TFJ JSN (L)Age, sex, baseline KL gradeNR*β* = −0.10, 95 % CI+Low (50)−0.18 to−0.02Wildi 2010 \[[@CR95]\]24-month regional change in TFJ BML score WORMS (L)24-month regional change in cartilage volume (L)nil*R* correlation coefficients all \<0.07NRNCLow (50)*p* \>0.367 for all three compartments at 24 monthsPelletier 2007 \[[@CR84]\]Regional Semi-quantitative baseline BML score (medial or lateral TFJ) (C)Regional cartilage volume over 24 months (medial or lateral TFJ) (L)NRLateral compartment BML scoreNRLow (50)*β* = −0.31, *p* = 0.001Driban 2011 \[[@CR79]\]Baseline BML volume (C) and 24 month change in BML volume (L) in TFJ compartments24-month change in full thickness cartilage lesion area (L)Age, sex, body mass indexNRBaseline BML volume *r* = 0.48, 95 % CI 0.20 to 0.69+Low (50)Baseline femur BML volume with loss in ipsicompartmental full thickness cartilage lesion area.*p* \<0.002Tanamas 2010 \[[@CR89]\]Baseline semi-quantitative MRI BML size (C) TFJCartilage volume change over 2 years (L) TFJ Incident TKR over 4 yearsAge, sex, BMI, baseline tibial cartilage volume and bone area*R* (95 % CI)*R* (95 % CI)+Low (50)Total cartilage lossTotal cartilage loss0.61 (−0.11 to 1.33)1.09 (0.24, 1.93)OR (95 % CI)OR (95 % CI)Incident TKRIncident TKR1.55 (1.04 to 2.29)1.57 (1.04 to 2.35)*p* = 0.03*p* = 0.03Madan-Sharma 2008 \[[@CR93]\]Baseline MRI semi-quantitative BML (C) TFJOARSI medial TFJ JSN grade progression over 2 years (L) TFJAge, sex, BMI, family effectNR0.9 RR,NALow (47)95 % CI 0.18 to 3.0Tanamas 2010 \[[@CR88]\]Semi-quantitative change in MRI BML severity (C)Incident TKR over 4 years (L)Age, gender, KL gradeOR (95 % CI)OR (95 % CI)+Low (47)Medial TFJMedial TFJAssociation in the medial TFJ but not in the lateral TFJ1.721.99(0.93 to 3.18)(1.01 to 3.90)*p* = 0.08*p* = 0.05Lateral TFJLateral TFJ0.95 (0.48 to 1.88)0.96 (0.48 to 1.94)*p* = 0.89*p* = 0.91Roemer 2012 \[[@CR86]\]Semi-quantitative BML (WORMS) TFJ and PFJ (C)Semi-quantitative cartilage score 6-month progression TFJ and PFJ (L)Age, sex, treatment, and BMI.NRBML TFJ OR 4.74, 95 % CI 1.14 to 19.5+Low (44)*p* = 0.032BMLs and cartilage score correlateBML PFJ OR, 1.63 (0.67 to 3.92)Crema 2013 \[[@CR78]\]MRI incident BML (WORMS)Progressive (30 month) semi-quantitative cartilage defect (WORMS) TFJ (L)Age, sex, BMI, malalignment, meniscal diseaseNROR (95 % CI)+Low (44)TFJMedial TFJ 7.6(L)(5.1 to 11.3)Lateral TFJ11.9 (6.2 to 23.0)Hernandez-Molina 2008 \[[@CR81]\]Crude presence of central BMLs on MRI (C) TFJSemi-quantitative cartilage defect (WORMS) (L) TFJAlignment, BMI, KL grade, sex, and age.NRMedial TFJ cartilage loss+Low (44)OR 6.1,95 % CI 1.0, 35.2Koster 2011 \[[@CR25]\]Baseline BML presence (C) TFJAny progression in KL grade over 1 year (L) TFJAge, BMIOR (95 % CI)OR (95 % CI)+Low (44)6.01 (1.92 to 18.8)5.29 (1.64 to 17.1)*p* = 0.002*p* = 0.005Hunter 2006 \[[@CR91]\]Change in MRI semi-quantitative BML score (L) TFJChange in semi-quantitative cartilage defect score (WORMS) (L) medial or lateral TFJLimb alignmentIpsilateral cartilage lossIpsilateral cartilage lossNA after adjustmentLow (44)*β* = 0.65*β* = 0.26*p* = 0.003*p* = 0.16Contralateral cartilage lossContralateral cartilage loss*β* = −0.27*β* = −0.16*p* = 0.22*p* = 0.52Roemer 2009 \[[@CR94]\]Baseline MRI BML crude presence or absence (WORMS) (L) TFJSemi-quantitative cartilage defect progression over 30 months (WORMS) (L) TFJAge, sex, race, BMI, alignmentOR (95 % CI)OR (95 % CI)NALow (44)Slow cartilage loss OR 1.74 (0.85 to 3.55)Slow cartilage loss OR 1.79 (0.83 to 3.87)Fast cartilage loss OR 1.32 (0.37 to 4.78)Fast cartilage loss OR 1.0 (0.24 to 4.10)Kubota 2010 \[[@CR92]\]MRI BML semi-quantitative volume score change over 6 months (L) TFJKL grade progression over 6 months (L) TFJNilBML score higher in KL progression groupNRNCLow (39)*p* = 0.044Driban 2012 abstract \[[@CR80]\]MRI BML volume change (L) TFJ over 24 monthsChange in cartilage thickness and denuded area of bone (L) TFJ over 24 monthsNilCartilage thicknessNR+Low (28)*r* = −0.34, *p* = 0.04denuded bone*r* = 0.42, *p* = 0.01Femoral cartilage indices *p* \>0.05Carrino 2006 \[[@CR77]\]Crude presence of MRI BML, TFJ (C) and (L)Any grade of cartilage defect TFJ (C) and (L)NilNRNR+Low (22)MRI bone marrow lesion - cross-sectional studiesBaranyay 2007 \[[@CR63]\]MRI BML defined as large or not large/absent in the medial and lateral compartments of TFJ (C)MRI semi-quantitative cartilage defects of medial and lateral compartments of TFJ (C)Age, gender, BMI, cartilage volume or bone areaOR (95 % CI)OR (95 % CI)+High (71 %)Quantitative cartilage volume medial and lateral TFJ (C)Cartilage defect Medial TFJCartilage defect Medial TFJCartilage defects1.81 (1.26 to 2.59) *p* = 0.0051.80 (1.21 to 2.69) *p* = 0.004NALateral TFJLateral TFJCartilage volume1.52 (1.14 to 2.04)1.45 (1.02 to 2.07)*p* = 0.005*p* = 0.04No association with ipsicompartmental cartilage volumeNo association with ipsicompartmental cartilage volumeGuymer 2007 \[[@CR35]\]Presence or absence of MRI BMLsPresence or absence of semi-quantitative cartilage defectsAge, height, weight, and tibial cartilage volumeOR (95 % CI)OR (95 % CI)+High (71)(C) TFJ(C) TFJMedial TFJMedial TFJA positive association is observed in the medial but not the lateral TFJ6.46 (1.04 to 38.39)3.51 (1.08 to 11.42)*p* = 0.04*p* = 0.04Lateral TFJLateral TFJ1.17 (0.22 to 6.26)1.02 (0.17 to 6.12)*p* = 0.85*p* = 0.98Stehling 2010 \[[@CR65]\]Presence of any MRI semi-quantitative BMLs (C)Presence of any WORMS MRI cartilage defects (C)Age, gender and BMI, KL score, knee injury or knee surgery, family history of TKR and Heberden\'s nodesNR*p* \<0.0001+High (71)Torres 2006 \[[@CR103]\]MRI BML (WORMS) (C) TFJ and PFJSemi-quantitative cartilage (WORMS) (C)Nil*R* = 0.56NR+High (68)Ip 2011 \[[@CR99]\]Semi-quantitative MRI BML (C)KL grade (C)Age, sex, BMI, OA stage, joint effusion, and meniscal damageNRHighest BML score *p* \<0.001+High (68)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI BML (C)KL grade (C)Nil*p* = 0.005NR+High (61)Kornaat 2005 \[[@CR100]\]Semi-quantitative MRI BML (KOSS)Semi-quantitative cartilage defects (KOSS) TFJ and PFJ (C)NilOR (95 % CI)NR+Low (57)PFJTFJ and PFJ (C)17 (3.8 to 72)TFJ120 (6.5 to 2,221)Gudbergsen 2013 \[[@CR98]\]Semi-quantitative MRI BML (BLOKS) (C)KL grade (C)NilKL gradeNR+Low (57)*p* = 0.046 lateral*p* \<0.001 medialLink 2003 \[[@CR101]\]Semi-quantitative MRI BML, (C)KL grade (C)Nil*p* \<0.05NR+Low (54)Sowers 2003 \[[@CR29]\]Semi-quantitative MRI BML (C)Semi-quantitative cartilage defect (C)Nil*p* for trendNR+Low (54)*p* \<0.0001Felson 2001 \[[@CR96]\]Semi-quantitative MRI BMLs (C)KL grade (C)NilNRNR+Low (54)Lo 2005 \[[@CR102]\]Semi-quantitative MRI BML (WORMS ≥ 1) (C)KL grade ≥ 2 (C)NilNRNR+Low (50)Meredith 2009 \[[@CR64]\]Sum of semi-quantitative MRISum of semi-quantitative MRINil*p* \<0.0003NR+Low (50)BML scores in the TFJ and PFJ (C)Cartilage defect scores in the TFJ and PFJ (C)Fernandez-Madrid 1994 \[[@CR97]\]Crude presence of MRI BMLs (C)KL grade (C)Nil*p* \<0.001NR+Low (46)Scher 2008 \[[@CR87]\]Semi-quantitative MRI BML (C)Semi-quantitative cartilage defect (modified Noyes) (C)Nil*p* = 0.012NR+Low (43)MRI bone marrow lesion - case control studiesRatzlaff 2014 \[[@CR104]\]Total tibial BML volume 12 and 24 months before TKR and interval change between 12 and 24 (C) and (L) TFJIncident TKR (L)NB matched cases and controlsOR (95 % CI)NR+High (65)12 months (C)True of TFJ but not PFJ1.68 (1.33 to 2.13)24 months (C)1.35 (1.02 to 1.78)12 to 24 months change (L)1.23 (1.03 to 1.46)Zhao 2010 \[[@CR105]\]Baseline crude presence of MRI BMLs at (C) TFJOverlying cartilage defect progression after 1 year (WORMS) (L) TFJNilChange in cartilage defect scores for areas with and without underlying BMLsNR+Low (56)*p* = 0.00003Aitken 2013 Abstract \[[@CR17]\]Semi-quantitative BMLs tibia, femur and patellaCartilage volume and defect score tibia and femurAge, sex, BMINRTibial cartilage volume-Low (47)*β* = −433 mm^3^ per unit increase in BML*p* \<0.01Stahl 2011 \[[@CR41]\]Semi-quantitative MRI BML size (WORMS) (L) TFJSemi-quantitative cartilage defect size (L) TFJNilNR*p* \<0.165NALow (47)MRI osteophyte - cohort studiesDe-Lange 2014 abstract \[[@CR106]\]Semi-quantitative osteophyte (KOSS) (C)Radiographic progression of JSN of TFJ (L)Age, gender, BMI and baseline JSNNROR (95 % CI)+High (61)1.8 (1.1 to 3.1)Higher OST score, the higher the JSNLiu 2014 Abstract \[[@CR45]\]Baseline semi-quantitative osteophyte score (WORMS) (C) TFJIncident TKR at 6-months follow up (L)Activity of daily living disability scoreNRRR (95 % CI) 3.01 (1.39 to 6.52)+Low (50)Sowers 2011 \[[@CR28]\]Semi-quantitative MRI osteophyte size in TFJ (C)Progression in KL grade (11-year follow up) (L)Nil*R* (95 % CI) medial tibia \~ 0.65 (0.59 to 0.71)NR+Low (53)Lateral tibia \~0.57 (0.49 to 0.63)MRI osteophyte - cross-sectional studiesStehling 2010 \[[@CR65]\]Presence of any MRI semi-quantitative osteophytes (C)Presence of any WORMS MRI cartilage defects (C)Age, gender and BMI, KL score, knee injury or knee surgery, family history of TKR and Heberden's nodesNR*p* = 0.0037+High (71)Torres 2006 \[[@CR103]\]MRI osteophyte, (WORMS) TFJ and PFJ (C)Semi-quantitative cartilage (WORMS) TFJ and PFJ (C)Nil*R* = 0.73NR+High (68)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI osteophyte (C)KL grade (C)Nil*p* \<0.001NR+High (61)Meredith 2009 \[[@CR64]\]Sum of semi-quantitative MRISum of semi-quantitative MRINil*p* \<0.0001NR+Low (50)Osteophyte scores in the TFJ and PFJ (C)cartilage defect scores in the TFJ and PFJ (C)McCauley 2001 \[[@CR26]\]MRI central osteophyte presence (C) TFJMRI cartilage lesion presence (C) TFJNilCrude association of 32 of 35 central osteophytes having adjacent cartilage lesionsNR+Low (29)Crude, unadjustedRoemer 2012 \[[@CR108]\]MRI osteophyteCartilage defect (WORMS) (C)Age, sex, BMI, race, TFJ radiographic OAOR 2378.1,OR 108.8,+Low (57)95 % CI 249.8 to 22643.495 % CI 14.2 to 834.9(WORMS) (C)*p* for trend \<0.0001Link 2003 \[[@CR101]\]Semi-quantitative MRI osteophytes (C)KL grade (C)Nil*p* \<0.01NR+Low (54)Fernandez-Madrid 1994 \[[@CR97]\]Crude presence of MRI osteophytes (C)KL grade (C)Nil*p* \<0.001NR+Low (46)MRI bone attrition - cohort studiesKothari 2010 \[[@CR82]\]Semi-quantitative baseline MRI attritionSemi-quantitative cartilage defect score change over 2 years (WORMS) (L) TFJ.Age, sex BMI, other bone lesionsOR 3.17,OR 1.85,NALow (50)95 % CI 1.64 to 6.1695 % CI 0.71 to 4.82(WORMS) (C) TFJMRI bone attrition - cross-sectional studiesTorres 2006 \[[@CR103]\]MRI attrition (WORMS) TFJ and PFJ (C)Semi-quantitative cartilage (WORMS) TFJ and PFJ (C)Nil*R* = 0.75NR+High (68)Reichenbach 2008 \[[@CR110]\]Semi-quantitative MRI bone attrition (WORMS) (C)KL grade and semi-quantitative cartilage defects (WORMS) (C)NilNRNR+Low (43)Crude correlationMRI bone attrition - case control studiesNeogi 2009 \[[@CR109]\]Baseline semi-quantitative MRI bone attrition size (WORMS) (C) TFJCartilage defects progression (WORMS) after 30 months TFJAge, sex, BMIOR 5.5,OR 3.0,+Low (59)95 % CI 3.0 to 10.095 % CI 2.2 to 4.2MRI bone Shape/dimension -- cohort studiesCicuttini 2004 \[[@CR111]\]Baseline quantitative MRI tibial bone area (C)TKR incidence (L) over 4 yearsAge, sex, height, weight, BMI, WOMAC, ROA severityNROR (95 % CI)+High (78)1.2 (1.0 to 1.4)*p* = 0.02Ding 2008 \[[@CR20]\]Baseline MRI tibial bone area (C) TFJProgressive cartilage volume loss (L) TFJAge, sex, BMI, OA family history, muscle strength and ROA.*β* (95 % CI)*β* (95 % CI)-High (72)Medial femoral cartilageMedial femoral cartilage*β* = 0.17 (0.04 to 0.29)*β* = 0.35 (0.14 to 0.56)Total femoral cartilageTotal femoral cartilage*β* = 0.07*β* = 0.13(0.003 to 0.14)(0.02 to 0.25)Ding 2006 \[[@CR18]\]Baseline MRI tibial bone area (C) TFJChange in semi-quantitative MRI cartilage defect scores over 2.3 years (L) TFJAge, sex, BMI, radiographic OA \\featuresNAOR (95%CI)-High (61)Medial TFJ1.24 (1.01 to 1.51)*p* = 0.04Lateral TFJ2.07 (1.52 to 2.82)*p* \<0.001Everhart 2014 \[[@CR114]\]Baseline TFJ subchondral surface ratio of medial and lateral TFJ compartments (C)Radiographic progression of lateral or medial TFJ knee OA at 48 months (L)Sex, race, age, BMI, tobacco use, activity level, knee coronal alignment, baseline symptoms, injury history, surgery history, KL grade, and JSWUnadjusted medial SSR vs progression of medial JSNNeither medial nor lateral SSR was associated lateral or medial ROA progression in adjusted analysis *p* \<0.05.NAHigh (61)OR 1.43, 95 % CI 1.15 to 1.77*p* = 0.0015Medial SSR vs progression of lateral JSNOR 1.87, 95 % CI 1.44 to 2.42*p* \<0.001Davies-Tuck 2008 \[[@CR112]\]Baseline MRI tibial bone plateau area (C) TFJProgressive semi-quantitative cartilage defect score (L) medial and lateral TFJAge, sex, BMI, baseline cartilage defect score, baseline cartilage volume and baseline tibial plateau areaLateral TFJOR (95 % CI)+High (56)OR (95 % CI) −0.01 (−0.06 to 0.03) *p* = 0.59Lateral TFJ 0.06 (0.004 to 0.11) *p* = 0.03 Medial TFJ 0.07 (0.03 to 0.12) *p* = 0.002Carnes 2012 \[[@CR113]\]MRI tibial bone area (C)Semi-quantitative cartilage defect progression TFJ (L)Age, sex, BMI, cartilage defects, BMLLateral tibial bone area OR 1.11, 95 % CI 1.0 to 1.23OR (95 % CI) bone area medial 1.12 (1.01 to 1.26) and lateral tibial (1.35 (1.12 to 1.63)+Low (50)Dore 2010 \[[@CR68]\]Baseline tibial bone area MRI (C)Increase or no increase in semi-quantitative MRI tibial cartilage defects over 2.7 years (L)Age, sex, body mass index, baseline cartilage defects, and subchondral bone mineral densityNROR (95 % CI) medial tibia 1.6 (1.0 to 2.6) *p* = 0.04 lateral tibia 2.4 (1.4 to 4.0) *p* \<0.01+ Bone area size is associated with increasing cartilage defect scoresLow (50)Hudelmaier 2013 \[[@CR180]\] AbstractAnnual change in segmented MRI knee bone area (L)Baseline KL grade (C)NilMedial tibia *p* \<0.05NR+ The higher the KL grade the larger the increase in bone areaLow (50)MRI bone shape/dimension - cross-sectional studiesDing 2005 \[[@CR19]\]MRI quantitative tibial bone area (C)Semi-quantitative MRI knee cartilage defect severity scores (C) TFJAge, sex, BMI, family history, cartilage volume*β* (95 % CI) medial TFJ 0.06 (0.03 to 0.09) lateral TFJ 0.09 (0.05 to 0.13)*β* (95 % CI) medial TFJ 0.11 (0.07 to 0.15) lateral TFJ 0.17 (0.11 to 0.22)+ Association maintained for the whole TFJ and by compartmentHigh (64)Kalichman 2007 \[[@CR165]\]MRI patellar length ratio, trochlea sulcus angle (C)JSN grade (C)Age, sex, BMINRTrochlea sulcus angle *p* for trend, medial JSN *p* = 0.0162, lateral JSN *p* = 0.1206NCHigh (64)Kalichman 2007 \[[@CR115]\]MRI patellar length ratio, trochlea sulcus angle (C)Cartilage defect (WORMS) (C)Age, sex, BMINRTrochlea sulcus angle *p* for trend, medial cartilage loss *p* = 0.0016, lateral cartilage loss *p* = 0.0009+Low (57)Stefanik 2012 \[[@CR116]\]MRI lateral trochlear inclination and trochlear angle (C)Semi-quantitative cartilage defect (WORMS) (C)Age, sex, BMINRLateral trochlear inclination OR 2, 95 % CI 1.9 to 3.7, *p* \<0.0001, trochlear angle OR 2.0, 95 % CI 1.2 to 3.5, *p* \<0.0001+Low (57)Frobell 2010 \[[@CR107]\]MRI bone area - manual segmentation (C)KL grade, OARSI JSN grade (C)Age and BMIMedial tibia JSN and KL p \<0.0125Medial tibia JSN and KL *p* \<0.0125+Low (57)Wang 2005 \[[@CR66]\]Annual % change in tibial bone area (L) 2 years follow upBaseline JSN (C)Age, sex, BMI, WOMAC score, SF-36 score, physical activity, radiographic OA features, baseline tibial plateau bone area.*β* (95 % CI) medial tibia *β* = 0.35 (−1.10 to 1.80) *p* = 0.63, lateral tibia −0.87 (−2.35 to 0.61) *p* = 0.25*β* (95 % CI) medial tibia 1.88 (0.43 to 3.33) *p* = 0.01 lateral tibia −0.42 (−2.31 to 1.48) *p* = 0.66+ Association with medial tibia but not in the lateral tibiaLow (57)Jones 2004 \[[@CR23]\]Tibial bone area (MRI) (C)Radiographic JSN (C)Age, sex, height, weight*β* (95 % CI) medial tibia *β* = −0.03 (−0.11 to 0.06), lateral tibia −0.00 (−0.07 to 0.06)β (95 % CI) medial tibia *β* = −0.00 (−0.04 to 0.06), lateral tibia +0.00 (−0.04 to 0.05)NALow (50)Eckstein 2010 \[[@CR117]\]MRI tibial bone area (segmented) (C)OARSI JSN grade (C)Nil*p* \<0.01NR+Low (43)MRI bone shape/dimension - case--control studiesBowes 2013 \[[@CR118]\]Change in segmented MRI 3D bone area over 4 years (L)KL grade defined ROA knee (C) and (L)NilNR bone area increased significantly faster in ROA vs non-ROA *p* \<0.0001NR+ Higher KL grades had greater increase in bone area,High (71)Neogi 2013 \[[@CR120]\]MRI 3D bone shape (tibia, femur and patella) (C)Incident TFJ ROA KL grade ≥2 (L)Age, sex, BMINROR 3, 95 % CI 1.8 to 5.0+ Developing 3D OA knee shape is associated with increasing ROA kneeHigh (65)Hunter 2013 abstract \[[@CR119]\]Change in MRI knee bone area over 24 months (L)Incident TFJ ROA (KL grade ≥2) (L)NRNRHazard ratio (95 % CI) range from 1.17 (1.08 to 1.27) to 3.97 (2.38 to 6.63), all highly statistically significant+ for all bone regions Enlarging bone area associated with increasing ROA kneeLow (59)Wluka 2005 \[[@CR121]\]Change in MRI tibial bone area (L)Baseline radiographic JSN (C)Age, BMI, pain, physical activityMedial tibial bone area *R* = 160, 95 % CI 120 to 201, *p* \<0.001Medial tibial bone area *R* = 145, 95 % CI 103 to 186, *p* \<0.001+Low (47)MRI bone cyst - cohort studiesKotharii 2010 \[[@CR82]\]Semi-quantitative baseline MRI bone cyst (WORMS) (C) TFJSemi-quantitative cartilage defect score change over 2 years (WORMS) (L) TFJ.Age, sex BMI, other bone lesionsOR 1.66, 95 % CI 0.55 to 4.99OR 0.47, 95 % CI 0.11 to 2.03NALow (50)Tanamas 2010 \[[@CR88]\]Semi-quantitative change in MRI bone cyst size (L)Knee Cartilage volume loss over 2 years (L) TFJNil*β* (95 % CI) lateral tibial cartilage loss in cyst regression relative to stable and progressive cystsNR+Low (47)*β* = −11.81 (−16.64 to −6.98)Madan-Sharma 2008 \[[@CR93]\]Baseline MRI semi-quantitative bone cyst (C) TFJOARSI medial TFJ JSN grade progression over 2 years (L) TFJAge, sex, BMI and family effectNR*RR* 1.6, 95 % CI 0.5 to 4.0NALow (47)Carrino 2006 \[[@CR77]\]Crude presence of MRI bone cyst TFJ (C) and (L)Any grade of cartilage defect TFJ (C) and (L)NilNRNR+Low (22)MRI bone cyst --- cross-sectional studiesStehling 2010 \[[@CR65]\]Presence of any MRI semi-quantitative cyst (C)Presence of any WORMS MRI cartilage defects (C)Age, gender and BMI, KL score, knee injury or knee surgery, family history of TKR and Heberden's nodesNR*p* = 0.0131+High (71)Torres 2006 \[[@CR103]\]MRI bone cyst (WORMS) TFJ and PFJ (C)Semi-quantitative cartilage (WORMS) TFJ and PFJ (C)Nil*R* = 0.75NCHigh (68)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI bone cyst (C)KL grade (C)Nil*p* = 0.02NR+High (61)Link 2003 \[[@CR101]\]Crude presence of MRI bone cyst (C)KL grade (C)Nil*p* \<0.01NR+Low (54)Crema 2010 \[[@CR122]\]MRI Bone cysts (WORMS) (C)Cartilage defect (WORMS) (C)NilNRNR+Low (50)CT bone cyst -- cross-sectional studiesOkazaki 2014 \[[@CR40]\]Number of CT bone cysts (medial femur and tibia) (C)Knee KL grade (C)Nilp \<0.05Nil+with KL grade in medial TFJLow (50)MRI subchondral bone morphometry - cohort studiesLo 2012 Abstract \[[@CR53]\]MRI BVF, trabecular number, thickness and spacing (C)OARSI medial TFJ JSN progression between 24 and 48 months (L)NilOR 2.4, 95 % CI 1.1 to 5.0, *p* = 0.02NRBVF, trabecular number and thickness are positively associated with JSN progression but negatively associated with trabecular spacing.Low (50)MRI subchondral bone morphometry - cross-sectional studiesDriban 2011 \[[@CR50]\] AbstractMRI bone volume fraction, trabecular number, spacing & thickness of medial tibia (C)The presence of any grade of radiographic medial & lateral JSN (C)Nil*R* = 0.09 to 1.77NR+ Medial JSN associated with higher BVF, trabecular number and thickness but lower spacingHigh (71)Driban 2011 \[[@CR49]\]MRI bone volume fraction (C)Radiographic JSN (C)NilNRNR+ Higher JSN score, lower JSW) were associated with higher BVFHigh (64)Lindsey 2004 \[[@CR123]\]MRI bone volume fraction trabecular and trabecular number (TFJ) (C)Cartilage volume of tibia or femur in contralateral TFJ compartment (C)NilMedial TFJ cartilage with lateral TFJ BVF and trabecular number. *β* = 0.29 to 0.36, *p* = 0.0020 to 0.02NR+ With contralateral BVF and trabecular number, but -- with trabecular spacingHigh (64)Lo 2012 \[[@CR54]\]MRI bone volume fraction, trabecular thickness, number, spacing and DXA BMD of (proximal medial tibia) (C)Radiographic medial JSN grade (C)NilAll *p* \<0.0001Nil+ (BV/TV, thickness, number, BMD) (spacing)High (64)Chiba 2012 \[[@CR34]\]MRI bone volume fraction and trabecular thickness of the medial & lateral femur & tibia. (C)Metric JSW (radiographic) of the medial and lateral TFJ (C)NilBone volume fraction −0.48 (*p* \<0.001) trabecular thickness −0.51 (*p* \<0.001)NR-Low (57)DXA BMD - cohort studiesDore 2010 \[[@CR68]\]Baseline proximal tibial BMD, DXA (C)Increase or no increase in semi-quantitative MRI tibial cartilage defects over 2.7 years (L)Age, sex, BMI, baseline cartilage defects and subchondral tibial bone areaNROR (95 % CI) medial tibia 1.6 (1.2 to 2.1) *p* \<0.01 lateral tibia 1.2 (0.9, 1.6) *p* = 0.19+ Association only observed in medial tibiaLow (50)Lo 2012 Abstract \[[@CR53]\]DXA-measured medial:lateral periarticular BMD (paBMD) (C)OARSI medial TFJ JSN progression (L)NilOR 8.4, 95 % CI 2.8 to 25.0, *p* \<0.0001nil+ JSN association with baseline M:L paBMDLow (50)Bruyere 2003 \[[@CR42]\]Subchondral tibial bone BMD (DXA) (C)Minimum medial JSW TFJ after one year (L)Age, sex, BMI, minimum JSWNR*R* = −0.43, *p* = 0.02Negative correlation i.e., lower BMD gives bigger JSW or less JSNLow (44)DXA BMD - cross-sectional studiesDore 2009 \[[@CR52]\]DXA tibial subchondral BMD (C)Radiograph JSN grade and MRI cartilage defect and volume (C)Age, sex BMINRMedial tibial BMD vs JSN *R* = 0.11, *p* \<0.01, defect *R* = 0.16, *p* \<0.01, cartilage volume *R* = 0.12, *p* = 0.01+ Higher the BMD the greater the JSN and cartilage defects,High (71)Lo 2006 \[[@CR55]\]DXA medial:lateral BMD ratio at the tibial plateau (C)Radiographic JSN grade (medial and lateral TFJ) (C)Age, sex, BMI*p* \<0.0001NR+ With medial JSN, − with lateral JSNHigh (71)Lo 2012 \[[@CR54]\]DXA BMD (proximal medial tibia) (C)Radiographic medial JSN grade (C)Nil*p* \<0.0001NR+High (64)Akamatsu 2014 \[[@CR31]\] AbstractBMD (DXA) (C) (medial tibia and femoral condyle)Medial TFJ JSN (radiographic) (C)NilTibia *R* = 0.571, *p* \<0.001 femur *R* = 0.550, *p* \< 0.001NR+ Medial femoral and tibial condyle BMD correlated with medial JSNLow (57)Volumetric CT BMD - case control studiesBennell 2008 \[[@CR56]\]Volumetric BMD in tibial subchondral trabecular bone (C)KL grade (C)Age, sex, BMINR*p* \<0.05NC BMD falls in posterior tibial plateau as KL increases but anteriorly increase in BMD notedLow (59)Knee scintigraphic subchondral bone cohort studiesMazzuca 2004 \[[@CR37]\]Baseline late-phase subchondral bone scintigraphy (adjusted for healthy diaphysis uptake) of the medial tibia and whole knee (C)Progression of minimum JSN of the medial TFJ from baseline to 30 months (L)Age, BMI, KL grade (NB all women)*r* = 0.22 to 0.30 (*p* \<0.05)*r* = 0 to 0.08 (*p* \<0.05)NA after adjustment for covariatesHigh (56)Mazzuca 2005 \[[@CR38]\]Baseline late-phase subchondral bone scintigraphy (adjusted for healthy diaphysis uptake) of the medial tibia and whole knee (C)Progression of minimum JSN of the medial TFJ from baseline to 30 months (L)Baseline JSW, treatment groupNRCoefficient 0.221, 95 % CI 0.003 to 0.439, *p* = 0.049+ The greater the scintigraphic bone signal the greater the JSNHigh (56)Dieppe 1993 \[[@CR58]\]Baseline late and or early-phase subchondral bone scintigraphy signal (C)Progression of JSN by ≥2 mm or knee operation incidence after 5 years (L)Nil*p* \<0.005NR+Low (50)Knee scintigraphic subchondral bone cross-sectional studiesKraus 2009 \[[@CR59]\]Ipsilateral late-phase bone scintigraphy, semi-quantitative retention scoring of TFJ (C)Ipsilateral OARSI scale of JSN (C)Age, gender, BMI, osteophyte OARSI score, knee alignment knee symptomsCoefficient 0.47 to 0.48 (*p* \<0.0001)Coefficient 0.26 to 0.29 (*p* = 0.0005 to 0.001)+High (71)McCrae 1992 \[[@CR62]\]Late-phase 'extended bone uptake' pattern bone scintigraphy, presence around the TFJ (C)Radiographic JSN presence (C)NilOR 47.3, 95% CI 6.4 to 352, *p* \<0.01NR+Low (50)2D knee bone shape -- cross-sectional studiesHaverkamp 2011 \[[@CR36]\]2D bone shape knee. 1. Femur and tibial width 2. Elevation of lateral tibial plateau (C)1. Presence of diffuse cartilage defects semi-quantitative scoring (MRI). 2. Presence of ROA knee (KL ≥2) (C)NB (this is a population of women only) ROA models adjusted for age, BMI; cartilage defect models adjusted for KL onlyOR (95 % CI) bone width vs knee ROA 2.03 (1.55 to 2.66) *p* \<0.001 bone width Presence of diffuse cartilage defects *p* \<0.001OR (95 % CI) knee ROA 1.94 (1.44 to 2.62) *p* \<0.001+ Wider bones and elevated tibial plateau were associated with the presence of ROA knee. Cartilage defects were only associated with bone widthLow (46)Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). *BMD* bone mineral density, *BMI* body mass index, *BML* bone marrow lesion, *BOKS* Boston osteoarthritis of the knee study, *BLOKS* Boston--Leeds osteoarthritis knee score, *BVF* bone volume fraction, *C* a feature or outcome described in cross-section, *CT* computed tomography, *DXA* dual-energy x-ray absorptiometry, *GARP* Genetics, osteoarthritis and progression study, *JSN* joint space narrowing, *JSW* joint space width, *KL* Kellgren-Lawrence, *KOSS* knee osteoarthritis scoring system, *L* a feature or outcome described longitudinally, *MAK-*2 mechanical factors in arthritis of the knee 2. *NC* no conclusion could be found for an association between bone feature and outcome measure, *SWAN* Michigan study of women's health across the nation, *MOST* multicentre osteoarthritis study, *MRI* magnetic resonance imaging, *NA* no association. *NR* not reported, *OA* osteoarthritis, *OAI* Osteoarthritis Initiative, *OR* odds ratio, *RR* relative risk ratio, *SSR* subchondral surface ratio *TASOAC* Tasmanian older adult cohort, *TFJ* tibiofemoral joint, *VAS* visual analogue scale, *WOMAC* Western Ontario and McMaster Universities arthritis index, *WORMS* whole-organ magnetic resonance imaging score, *CRP* C-reactive protein, *TKR* total knee replacement, *OARSI* Osteoarthritis Research Society International, *PFJ* patellofemoral joint, *ROA* radiographic osteoarthritis

### Bone marrow lesions {#Sec12}

MRI (31 cohort, 15 cross-sectional, 4 case--control studies): in prospective cohorts with high- quality, well-adjusted analyses the presence and increasing size of baseline BMLs and incidence of BMLs conferred greater odds of structural progression \[[@CR67], [@CR70]--[@CR73]\]. Similarly increasing baseline BML size increased the risk of total knee replacement (TKR) and expedited the outcome of TKR \[[@CR44], [@CR74]--[@CR76]\]. The association between BMLs and structural progression of OA was maintained in cohorts without clinical features of knee OA \[[@CR67]\] and in analyses with poorer quality or statistical adjustment \[[@CR25], [@CR28], [@CR76]--[@CR90]\]. Only five low quality cohort analyses did not support these findings \[[@CR91]--[@CR95]\]. All cross-sectional analyses found positive correlation between BMLs and structural severity of OA \[[@CR22], [@CR29], [@CR35], [@CR63]--[@CR65], [@CR87], [@CR96]--[@CR103]\]. Three case--control analyses found similar associations \[[@CR17], [@CR104], [@CR105]\]. In summary, BMLs are independently associated with structural progression of OA of the knee and incident TKR.

### Osteophytes {#Sec13}

MRI (three cohorts, eight cross-sectional studies): in one prospective cohort with high quality and well-adjusted analysis, the increasing size of osteophytes conferred greater odds of structural progression of OA \[[@CR106]\]. In lower quality, inadequately adjusted, prospective cohorts, increasing osteophyte size increased the risk of incident TKR and structural progression of OA \[[@CR28], [@CR45]\]. The increasing size and presence of osteophytes was associated with greater structural progression or severity in all included analyses \[[@CR22], [@CR26], [@CR28], [@CR45], [@CR64], [@CR65], [@CR97], [@CR101], [@CR103], [@CR106]--[@CR108]\]. In summary, osteophytes are independently associated with knee structural progression and are associated with TKR incidence.

### Bone attrition {#Sec14}

MRI (one cohort, two cross-sectional, one case--control study): one prospective, well-adjusted, but below-average-quality cohort analysis found an association with baseline attrition severity and structural progression that became insignificant after covariate adjustment \[[@CR82]\]. The unadjusted cross-sectional analyses and case--control analysis found similar associations with structural severity \[[@CR103], [@CR109], [@CR110]\]. In summary, bone attrition is associated, but not independently so, with structural progression.

### Bone shape/dimension {#Sec15}

MRI (eight cohort, seven cross-sectional, four case--control studies): in prospective cohorts with high quality well-adjusted analyses, greater baseline tibial plateau bone area conferred greater odds of structural progression of OA and incidence of TKR \[[@CR18], [@CR20], [@CR111], [@CR112]\]. The same association was observed in a lower quality, prospective-cohort, well-adjusted analysis \[[@CR113]\] and in a study of the knee in patients who predominantly had no radiographic evidence of knee OA \[[@CR18]\]. The mismatch ratio of the femoral and tibial articulating areas was not associated with structural progression after adjustment \[[@CR114]\], but the trochlear sulcus angle and shape was associated with cross-sectional patellofemoral structural severity demonstrated on MRI \[[@CR115], [@CR116]\]. All cross-sectional \[[@CR23], [@CR66], [@CR107], [@CR117]\] and case--control \[[@CR118]--[@CR121]\] analyses of tibial bone area or 3D knee bone shape found association with structural severity \[[@CR23], [@CR66], [@CR107], [@CR117]--[@CR121]\]. In summary, tibial bone area is independently associated with structural progression of OA of the knee and incidence of TKR.

### Bone cyst {#Sec16}

MRI and CT (five cohort, five cross-sectional) studies: two prospective cohorts with well-adjusted but below-average-quality analyses of cysts reported no association with structural progression of OA before or after adjustment \[[@CR82], [@CR93]\]. Two prospective cohorts with low quality unadjusted analyses of cysts found an association with structural progression of OA \[[@CR77], [@CR88]\]. Cross-sectional well-adjusted \[[@CR65]\] and unadjusted \[[@CR22], [@CR40], [@CR101], [@CR122]\] cyst analyses found an association with structural severity. In summary, after covariate adjustment there is no independent association between cysts and structural progression of OA.

### Trabecular bone morphometry {#Sec17}

MRI (one cohort, five cross-sectional studies): one prospective cohort, unadjusted, below-average-quality analysis reported increasing bone volume fraction, trabecular number and thickness and decreasing trabecular spacing were associated with structural progression \[[@CR53]\]. The same bone changes were associated with structural severity in cross-sectional unadjusted analyses \[[@CR34], [@CR49], [@CR50], [@CR54], [@CR123]\]. In summary, increasing bone volume fraction, trabecular number, trabecular thickness, and decreasing trabecular spacing are associated with structural progression and severity of OA of the knee.

### Peri-articular bone mineral density {#Sec18}

DXA and CT (three cohort, four cross-sectional, one--case control study): two prospective cohorts with well-adjusted but below-average-quality analyses reported that increasing tibial subchondral BMD is associated with structural progression of OA \[[@CR42], [@CR68]\]. In one prospective cohort with an unadjusted below-average-quality analysis, the medial-to-lateral ratio of tibial peri-articular BMD was associated with structural progression \[[@CR53]\]. All cross-sectional analyses \[[@CR31], [@CR52], [@CR54], [@CR55]\], including two that were well-adjusted \[[@CR52], [@CR55]\], reported increasing BMD with greater structural severity. One well-adjusted analysis using quantitative CT (qCT) reported higher and lower BMD in the anterior and posterior tibial plateau, respectively, in knees of patients with moderate OA relative to asymptomatic controls. In summary, increasing peri-articular radiographic BMD is associated with structural progression and severity of OA.

### Scintigraphy {#Sec19}

Scintigraphy (three cohort, two cross-sectional studies): prospective cohorts with high quality analyses found greater late-phase bone signal was associated with structural progression of OA, with no or inadequate covariate adjustment \[[@CR37], [@CR38]\], but not after adequate covariate adjustment \[[@CR37]\]. A prospective cohort, with below-average-quality, unadjusted analysis found greater bone signal was associated with structural progression of OA \[[@CR58]\]. Bone signal was associated with structural severity in well-adjusted and unadjusted cross-sectional analyses \[[@CR59], [@CR62]\]. In summary, bone scintigraphy signal is associated, but not independently so, with structural progression of OA.

### 2D Knee bone shape {#Sec20}

One cross-sectional, well-adjusted analysis identified an association between greater femoral and tibial bone width and elevating tibial plateau, and greater structural severity \[[@CR36]\]. In summary, 2D bone shape is associated with structural severity of OA.

Relationship between knee bone feature and pain {#Sec21}
-----------------------------------------------

The association between bone features and pain is described in Tables [2](#Tab2){ref-type="table"} and [5](#Tab5){ref-type="table"}. In all types of study, bone features were compared with the presence, chronicity and severity of pain. In longitudinal studies, bone features were also compared with change in the presence or severity of pain (e.g., change in Western Ontario and McMaster Universities arthritis index (WOMAC) pain score). Change in the presence of pain included developing new frequent pain, \[[@CR49]\], or the resolution of existing pain.Table 2Knee pain associations by feature and quality scoreAuthorFeature (method)Knee pain outcomeAdjustment for confoundersAssociation (magnitude) crudeAssociation (magnitude) adjustedAssociationQuality score (%)MRI bone marrow lesion - cohort studiesFoong 2014 \[[@CR21]\]Change in BML size (L) and incident BMLs (L) in all three knee compartmentsWOMAC Knee pain severity at 2-year and 10-year visits (L)Age, sex, BMI, leg strength, and the presence of ROANRIncident or change in total BML size *β* = 1.53 (95 % CI 0.37 to 2.70.+High (67)Medial tibial change in BML size *β* = 2.96 (95 % CI 0.59-5.34Incidence of BML or increase in size associated with increase in pain in the medial tibiaDriban 2013 \[[@CR72]\]Knee baseline BML volume (C), BML volume change (L) (TFJ)48-month change in WOMAC pain (L)Age, sex, BMINR*β* = 0.21+High (61)(standard error 0.07)Longitudinal (L) changes in BML correlated with (L) changes in pain severity*p* = 0.004Dore 2010 \[[@CR124]\]MRI BML size (L) regional or whole TFJ over 2.7 yearsChange in WOMAC pain (L) over 2.7 yearsAge, sex, BMI, leg strength, quality of life, and baseline pain, function*β* (95 % CI) Total BML size change = 1.06 (0.10 to 2.03)*β* (95 % CI) total BML size change = 1.13 (0.28 to 1.98)+High (56)Kornaat 2007 \[[@CR173]\]Semi-quantitative MRI BML change over 2 years (L) TFJMean WOMAC pain over 2 yearsAge, sex and BMINR*β* (95 % CI) = 2 (−8 to 11)NAHigh (56)Moisio 2009 \[[@CR125]\]Baseline MRI semi-quantitative BML score (C) TFJ and PFJIncident frequent knee pain 2 years after baseline (L)Age, sex, BMI, BML score, % denuded boneNROR (95 % CI) medial tibia and femur 1.41 (0.86 to 2.33), lateral tibia and femur 1.70 (1.07 to 2.69)+ Lateral TFJ BML score associated with incident frequent knee painHigh (56)Sowers 2011 \[[@CR28]\]Semi-quantitative MRI BML, size in TFJ (C)Increasing WOMAC pain (L)NilMedial and lateral TFJ BMLs both *p* \<0.005NR+Low (53)Zhang 2011 \[[@CR126]\]Semi-quantitative change in MRI BML size (L) TFJ over 30 monthsIncidence of frequent knee pain, and categorical severity (L) over 30 monthsSynovitis and effusionsOR (95 % CI) Severity of frequent knee pain OR 3.0 (1.5 to 6.0)OR (95 % CI) Incident frequent knee pain *p* for trend = 0.006. Severity of frequent knee pain OR 2.2 (1.0 to 4.7) *p* = 0.047+ Ipsilateral associationLow (50)Wildi 2010 \[[@CR95]\]24-month change in regional TFJ BML score WORMS (L)24-month change in WOMAC pain (L)Nil*R* \<0.15, *p* \>0.067 for all compartmentsNRNA, all compartments had no correlationLow (50)Tanamas 2010 \[[@CR89]\]Baseline semi-quantitative MRI BML size (C)Annual change in WOMAC pain (L)NilNRNRNALow (50)MRI bone marrow lesion - cross-sectional studiesZhai 2006 \[[@CR135]\]Semi-quantitative MRI BML (C)WOMAC pain \>1 (C)Age, BMI, sex, knee strength, chondral defectsNROR 1.44, 95 % CI 1.04, 2.00+High (79)Sharma 2014 \[[@CR133]\]Semi-quantitative BML score WORMS TFJ or PFJ (C)Prevalent frequent knee symptoms (C)Age, sex, body mass index (BMI), previous knee injury, and previous knee surgeryNRBMLs in any compartment OR 1.96, 95 % CI 1.38 to 2.77+ BML association with prevalent knee symptomsHigh (71)Kornaat 2006 \[[@CR130]\]Semi-quantitative MRI BML (C)Chronic pain presence (C)Age, sex, and BMINROR 1.13, 95 % 0.41, 3.11, *p* = 0.76NAHigh (71)Lo 2009 \[[@CR131]\]Semi-quantitative MRI BML (BLOKS) (C)WOMAC pain (C)Synovitis, effusion scores*p* for trend = 0.0009*p* for trend = 0.006+High (71)Stefanik 2014 abstract \[[@CR134]\]BML (WORMS) (C) (patellofemoral joint)Prevalent knee pain (any pain in last 30 days) and pain VAS (C)Adjusted for age, sex, BMI, depressive symptoms and TFJ BMLsNRIsolated BML of the lateral PFJ, OR (95 % CI) 1.4 (0.9 to 2.0); medial PFJ, OR (95 % CI) 1.1 (0.8 to 1.5). Isolated lateral PFJ BMLs OR 6.6 (1.7 to 11.5)NCHigh (71)Ratzlaff 2013 \[[@CR132]\]Total BML volume in the femur or tibia (C)Weight-bearing knee pain WOMAC subscale (C)Age, sex, BMI, race, and medial minimum joint space widthNRTotal BML volume femur *p* = 0.003, tibia *p* = 0.101+ Femoral NA TibialHigh (71)Ip 2011 \[[@CR99]\]Semi-quantitative MRI BML (C)WOMAC pain (C)Age, sex, BMI, OA stage, joint effusion, and meniscal damageNRTotal WOMAC painNCHigh (68)*R* = 0.05, 95 % CI −0.04 to 0.14. Stair climbing pain *R* = 0.09 (0.00 to 0.18)Torres 2006 \[[@CR103]\]MRI BML (WORMS) TFJ and PFJ (C)Pain VAS (C)Age, BMICoefficient 5.00, 95 % CI 3.00 to 7.00Coefficient 3.72, 95 % CI 1.76 to 5.68+High (68)Kim 2013 \[[@CR129]\]Summary score and severity of MRI BML (WORMS) (C)WOMAC pain severity or presence of knee pain (C)Age, sex, BMI, radiographic OANRBML summary score medial TFJ OR 2.33, 95 % CI 1.02 to 5.33, *p* \<0.001+ Severity of BML is proportional to WOMAC in medial compartment after adjustmentHigh (64)Moisio 2009 \[[@CR125]\]Baseline MRI semi-quantitative BML score (C) TFJ and PFJPresence of baseline moderate to severe knee pain (C)Percent denuded bone, age, sex, BMINRBone marrow lesion score, OR 0.95, 95 % CI 0.63 to 1.44. Not significant in all compartmentsNA found on cross-sectional analysisHigh (64)Ratzlaff 2014 \[[@CR48]\] AbstractMedian BML volume (PFJ, TFJ) (C)Stair-climbing knee pain WOMAC (C)NilTFJ *p* = 0.01, patellofemoral *p* = 0.01, femur *p* = 0.02, tibia *p* = 0.03NR+High (64)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI BML (C)Chronic pain presence (C)Nil*p* = 0.001NR+High (61)Ai 2010 \[[@CR127]\]Semi-quantitative MRI BML (C)Pain verbal rating scale (Likert) (C)Nil*p* = 0.33NRNALow (57)Bilgici 2010 \[[@CR128]\]MRI BML (WORMS) (C)WOMAC pain, pain VAS (C)NilWOMAC *r* = 0.508, *p* \<0.01 Pain VAS *r* = 0.488, *p* \<0.01NR+Low (57)Sowers 2003 \[[@CR29]\]Semi-quantitative MRI BML (C)Chronic pain presence (C)NilOR 5.0, 95 % CI 2.4 to 10.5NR+Low (54)Link 2003 \[[@CR101]\]Semi-quantitative MRI BML (C)WOMAC pain (C)Nil*p* \>0.05NRNALow (54)Felson 2001 \[[@CR96]\]Semi-quantitative MRI BMLs (C)Chronic knee pain presence (C)Radiographic severity, age, sex, and effusion score*p* \<0.001OR 3.31, 95 % CI 1.54 to 7.41+Low (54)Fernandez-Madrid 1994 \[[@CR97]\]Crude presence of MRI BMLs (C)Crude pain presence (C)NilNRNRNALow (46)MRI bone marrow lesion - case−control studiesJavaid 2010 \[[@CR140]\]Baseline semi-quantitative MRI BML size (WORMS) (C) TFJ and PFJIncident frequent knee pain after 15 months (L)Age, sex, race, BMINRWhole knee OR 2.8, 95 % CI 1.2 to 6.5+High (76)Felson 2007 \[[@CR181]\]Semi-quantitative MRI BML size increase (WORMS) (L) TFJ and PFJIncident frequent pain at 15 months (L)Age, sex, race, BMI, quadriceps strength, KL score, malalignment, baseline BML scoreOR 4.1, 95 % CI 2.1 to 8.1OR 3.2, 95 % CI 1.5 to 6.8+High (71)Javaid 2012 \[[@CR139]\]Baseline Semi-quantitative MRI BML, (WORMS) (C) TFJ and PFJPresence of frequent knee pain (C) after 2 yearsNilOR 1.70, 95 % CI 1.08 toNR+Low (59)Zhao 2010 \[[@CR105]\]Baseline crude presence of MRI BMLs at (C) TFJChange in WOMAC Pain (L)Nil*p* = 0.60NRNALow (56)Stahl 2011 \[[@CR41]\]Semi-quantitative MRI BML size (WORMS) (L) TFJChanges in WOMAC score (L)NilNRData not shownNALow (47)MRI osteophyte -- cohort studiesSowers 2011 \[[@CR28]\]Semi-quantitative MRI osteophyte, size in TFJ (C)Increasing WOMAC pain (L)NilMedial and lateral TFJ BMLs both *p* \<0.001NR+Low (53)MRI osteophyte - cross-sectional studiesKornaat 2006 \[[@CR130]\]Semi-quantitative MRI osteophyte (C)Chronic pain presence (C)Age, sex, BMINRPatellofemoral OR 2.25, 95 % CI 1.06 to 4.77+High (71)Sengupta 2006 \[[@CR136]\]Semi-quantitative MRI osteophyte (WORMS) (C)Pain severity WOMAC, chronic pain (C)Age, sex, BMINROR 0.97, 95 % CI 0.86 to 1.10NAHigh (71)Torres 2006 \[[@CR103]\]MRI osteophyte, (WORMS) TFJ and PFJ (C)Pain VAS (C)NilCoefficient 1.18, 95 % CI 0.63 to 1.72Coefficient 0.50, 95 % CI 0.07 to 0.94NCHigh (68)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI osteophyte (C)Chronic pain presence (C)Nil*p* \<0.001NR+High (61)Ai 2010 \[[@CR127]\]Semi-quantitative MRI osteophytes (C)Pain verbal rating scale (Likert) (C)Nil*p* = 0.166NRNALow (57)Hayashi 2012 \[[@CR137]\]Crude presence of MRI osteophytes (C)Presence of pain on WOMAC pain subscale (C)NilOR 4.2 to 6.4, *p* = 0.001-0.011NR+Low (57)Link 2003 \[[@CR101]\]Semi-quantitative MRI osteophytes (C)WOMAC pain (C)Nil*p* \>0.05NRNALow (54)Fernandez-Madrid 1994 \[[@CR97]\]Crude presence of MRI osteophytes (C)Crude pain presence (C)NilNRNRNALow (46)MRI osteophyte - case--control studiesJavaid 2010 \[[@CR140]\]Baseline semi-quantitative MRI osteophyte, size (WORMS) (C) TFJ and PFJIncident frequent knee pain after 15 months (L)Age, sex, race, BMINRWhole knee severe osteophyte OR 4.7, 95 % CI 1.3 to 18+High (76)MRI bone attrition - cross-sectional studiesHernandez-Molina 2008 \[[@CR138]\]Semi-quantitative MRI bone attrition (WORMS) (C)Pain severity and nocturnal pain (WOMAC) (C)Age, sex, BMI, BMLs, effusions and KL gradeOR (95 % CI) pain severity OR 1.6 (1.1 to 2.3), nocturnal pain OR 1.1 (0.5 to 2.1)OR (95 % CI) pain severity OR 0.9 (0.6 to 1.4), nocturnal pain OR 1.0 (0.5 to 2.1).NAHigh (71)Torres 2006 \[[@CR103]\]MRI attrition, (WORMS) TFJ and PFJ (C)Pain VAS (C)NilCoefficient 3.33, 95 % CI 1.79 to 4.87Coefficient 1.91, 95 % CI 0.68 to 3.13+High (68)MRI bone attrition - case−control studiesJavaid 2012 \[[@CR139]\]Baseline semi-quantitative MRI attrition size (WORMS) (C) TFJ and PFJPresence of frequent knee pain (C) after 2 yearsNilOR 2.40, 95 % CI 1.51 to 3.83NR+Low (59)MRI bone shape/dimension - cohort studiesEverhart 2014 \[[@CR114]\]Baseline TFJ subchondral surface ratio of medial and lateral TFJ compartments (C)Incident frequent knee pain at 48 months, (L)Sex, race, age, BMI, tobacco use, activity level, knee coronal alignment, baseline symptoms, injury history, surgery history, KL grade, and JSWNRMedial SSR OR 0.48, 95 % CI 0.30 to 0.75, *p* = 0.0009. Lateral SSR OR 1.27, 95 % CI 0.86 to 1.88, *p* = 0.19- larger MSSR gets less incident frequent knee painHigh (61)MRI bone shape/dimension - cross-sectional studiesOchiai 2010 \[[@CR47]\]MRI irregularity of femoral condyle contour (C)Knee pain VAS (C)NilIrregularity of femoral condyle contour *r* = 0.472, *p* = 0.0021NR+Low (50)MRI bone cyst - cohort studiesSowers 2011 \[[@CR28]\]Semi-quantitative MRI bone cyst size in TFJ (C)Increasing WOMAC pain (L)NilNRNR analysis described as not significant but data not shownNALow (53)MRI bone cyst - cross-sectional studiesKornaat 2006 \[[@CR130]\]Semi-quantitative MRI bone cyst(C)Chronic pain presence (C)NilNRPatellofemoral OR 1.83, 95 % CI (0.80 to 4.16)NAHigh (71)Torres 2006 \[[@CR103]\]MRI bone cyst (WORMS) TFJ and PFJ (C)Pain VAS (C)Age, BMICoefficient 2.50, 95 % CI −0.38 to 5.38Coefficient 0.82, 95 % CI −0.50 to 2.14NAHigh (68)Hayes 2005 \[[@CR22]\]Semi-quantitative MRI bone cyst (C)Chronic pain presence (C)Age, sex, and BMI*p* \<0.001NR+High (61)Hayashi 2012 \[[@CR137]\]Crude presence of MRI bone cysts (C)Presence of pain on WOMAC pain subscale (C)NilOR 6.7 to 17.8, p = 0.004 to 0.03NR+Low (57)Link 2003 \[[@CR101]\]Crude presence of MRI bone cyst (C)WOMAC pain (C)Nil*p* \>0.05NRNALow (54)MRI bone cyst - case control studiesJavaid 2010 \[[@CR140]\]Baseline semi-quantitative MRI bone cyst size (WORMS) (C) TFJ and PFJIncident frequent knee pain after 15 months (L)NilNRNR *p* \>0.1NAHigh (76)Javaid 2012 \[[@CR139]\]Baseline semi-quantitative MRI bone cyst size (WORMS) (C) TFJ and PFJPresence of frequent knee pain (C) after 2 yearsNilOR 1.61, 95 % CI 1.03 to 2.52NR+Low (59)qCT bone mineral density - cross-sectional studiesBurnett 2012 \[[@CR57]\]BMD of patellar lateral facet (qCT) (C)WOMAC -- knee pain at rest (C)NilTotal lateral patella facet *p* = 0.04, inferior lateral facet *p* = 0.005NRLow (57)2D Knee bone shape - cross-sectional studiesHaverkamp 2011 \[[@CR36]\]2D Bone shape knee, 1. femur and tibial width, 2. elevation of lateral tibial plateau (C)Pain severity VAS (C)Models adjusted for Age, BMINRBone width *p* = 0.167, lateral tibia plateau elevation *p* = 0.002+ Lateral tibial plateau associated with pain severity, NA bone width with pain severityLow (46)Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). *BMI* body mass index, *BML* bone marrow lesion, *C* a feature or outcome described in cross-section, knee pain on most days for at least the last month (chronic pain) confidence interval (*CI*), *KL* Kellgren-Lawrence, *L* a feature or outcome described longitudinally, *NA* no association, *NC* no conclusion could be found for an association between bone feature and outcome measure, *NR* not reported, *OA* osteoarthritis, *OAI* Osteoarthritis Initiative, *OR* odds ratio, *PFJ* patellofemoral joint, *ROA* radiographic osteoarthritis, *SSR* subchondral surface ratio *VAS* visual analogue scale, *WOMAC* Western Ontario and McMaster Universities arthritis index, *qCT* quantitative computed tomography

### Bone marrow lesions {#Sec22}

MRI (9 cohort, 18 cross-sectional, 5 case--control studies): in 3 prospective cohort, well-adjusted, high quality analyses the baseline or longitudinal increase in size of BMLs was associated with longitudinally increasing knee WOMAC pain severity \[[@CR21], [@CR72], [@CR124]\]. This association was observed in one \[[@CR28]\] but not two \[[@CR89], [@CR95]\] similar prospective-cohort, unadjusted, lower quality analyses. Baseline BML size in the lateral but not the medial tibiofemoral joint was associated with incident frequent knee pain in a prospective-cohort, well-adjusted, high quality analysis \[[@CR125]\]. Longitudinally increasing BML size was associated with incident frequent knee pain in a similar but inadequately adjusted analysis of below average quality \[[@CR126]\]. In cross-sectional studies the size or presence of BMLs was inconsistently associated with the presence of a heterogenous range of pain measures, irrespective of adequate covariate adjustment \[[@CR22], [@CR29], [@CR48], [@CR96], [@CR97], [@CR99], [@CR101], [@CR103], [@CR125], [@CR127]--[@CR135]\]. In summary, BMLs are independently associated with longitudinally increasing pain severity and are associated with incident frequent knee pain.

### Osteophytes {#Sec23}

MRI (one cohort, eight cross-sectional, one case--control study): one prospective cohort, unadjusted, below-average-quality analysis reported increasing baseline osteophyte size was associated with increasing WOMAC pain severity score \[[@CR28]\]. In well-adjusted cross-sectional analyses, osteophyte size was associated with the presence \[[@CR130]\] but not severity of pain \[[@CR136]\]. In unadjusted cross-sectional analyses osteophytes were inconsistently associated with a heterogenous range of pain measures \[[@CR22], [@CR97], [@CR101], [@CR103], [@CR127], [@CR137]\]. In summary, osteophytes are associated with longitudinally increasing pain severity and the cross-sectional presence of pain.

### Bone attrition {#Sec24}

MRI (no cohort, two cross-sectional, one case--control study); cross-sectional analyses found greater attrition was associated with greater pain severity, without covariate adjustment \[[@CR103], [@CR138]\], but not after adequate covariate adjustment \[[@CR138]\]. An unadjusted case--control analysis found an association between attrition and prevalent pain \[[@CR139]\]. In summary, bone attrition is associated, but not independently so, with severity of pain.

### Bone shape/dimension {#Sec25}

MRI (one cohort, one cross-sectional study): one prospective, well-adjusted, high quality analysis found the femoro-tibial articulating surface mismatch was associated with incident frequent knee pain \[[@CR114]\]. One unadjusted cross-sectional analysis found the irregularity of the femoral condyle surface was associated with severity of knee pain \[[@CR47]\]. In summary, specific features of bone shape are independently associated with incident frequent knee pain and severity of pain.

### Bone cyst {#Sec26}

MRI (one cohort, five cross-sectional, two case--control studies): one prospective cohort, unadjusted, low quality analysis found no association between bone cyst size and increasing WOMAC pain score \[[@CR28]\]. In mostly unadjusted cross-sectional \[[@CR22], [@CR101], [@CR103], [@CR130], [@CR137]\] and case control analyses \[[@CR139], [@CR140]\] of heterogenous cyst measures and pain measures, an association between cysts and pain was inconsistently found. In summary, bone cysts may not be associated with longitudinal severity of pain and cross-sectional association with pain is uncertain.

### 2D Knee bone shape {#Sec27}

One inadequately adjusted cross-sectional analysis found an association between the elevation of the lateral tibial plateau and severity of pain \[[@CR36]\]. In summary, 2D lateral tibial bone shape is associated with cross-sectional severity of pain.

Relationship between hand bone feature and structural progression {#Sec28}
-----------------------------------------------------------------

The association between bone features and structural progression is described in Tables [3](#Tab3){ref-type="table"} and [5](#Tab5){ref-type="table"}.Table 3Hand, hip and ankle structural associations by feature and quality gradeAuthorFeature (method)Structural severity or progression outcomeAdjustment for confoundersAssociation (magnitude) crudeAssociation (magnitude) adjustedAssociationQuality (score %)Hand MRI bone marrow lesion case seriesHaugen 2014 \[[@CR141]\]BMLs - semi-quantitative at 2^nd^ to 5^th^ IPJs (C)Progression of hand ROA (JSN, KL grade or new erosion) (L)Age, sex, BMI,OR 2.73, 95 % CI 1.29 to 5.78NR+High (61)Bigger the BML, the more the JSNHand MRI bone marrow lesion cross-sectional studiesHaugen 2012 Abstract \[[@CR143]\] 299BML (Oslo MRI hand score) (C) IPJsRadiographic JSN grade IPJ (OARSI atlas) (C)Age, sex,OR 10.0, 95 % CI 4.2 to 23OR 4.4, 95 % CI 2.2 to 9.0+Low (43)BML score association with more JSNHaugen 2012 \[[@CR142]\]BML (Oslo MRI hand score) (C) IPJsHand KL grade of IPJs (C)Age, sexNROR (95 % CI)+High (64)BMLs 11 (5.5 to 21)*p* \<0.001Hand MRI osteophyte cross-sectional studiesHaugen 2012 \[[@CR142]\]Osteophyte (Oslo MRI hand score) (C) IPJsHand KL grade of IPJs (C)Age, sexNROR (95 % CI)+High (64)osteophytes415 (189 to 908)*p* \<0.001Hand MRI attrition cross-sectional studiesHaugen 2012 \[[@CR142]\]Attrition (Oslo MRI hand score) (C) IPJsHand KL grade of IPJs (C)Age, sexNROR (95 % CI) attrition 87 (37 to 204)+High (64)*p* \<0.001Hand MRI bone cyst cross-sectional studiesHaugen 2012 \[[@CR142]\]Cyst (Oslo MRI hand score) (C) IPJsHand KL grade of IPJs (C)Age, sexNROR (95 % CI)NilHigh (64)cysts 2.0 (0.6 to 6.3)*p* = 0.26Hip MRI BML cross-sectional studiesNeumann 2007 \[[@CR46]\]Semi-quantitative BMLs (C)Semi-quantitative cartilage lesions (C)Nil*R* = 0.44, *p* ≤0.001NR+ Correlation between BML and cartilage lesionsLow (43)Dawson 2013 Abstract \[[@CR69]\]Femoral head BMLs (MRI) (C)1. Presence of hip OA. 2. Femoral head cartilage volume (MRI) (C)Age, sex, BMINAOA hip presence+Low (14)BMLs associated with diagnosis of hip OAOR (95 % CI)5.32 (1.78 to 15.9)*p* = 0.003BMLs inversely associated with cartilage volumecartilage volumeregression coefficient (95 % CI)−245.7 mm^3^(−456 to −36) *p* = 0.02Hip CT bone morphometry cross-sectional studiesChiba 2011 \[[@CR33]\]Acetabular and femoral head subchondral trabecular morphometry: bone volume fraction, trabecular thickness, number, separation (CT) (C)Hip joint space volume (CT) (C)NilFemoral head Bone volume fraction *r* = −0.691, *p* \<0.001NRJoint space narrowing is associated with increased bone volume fraction, trabecular thickening. trabecular number and spacing decreaseLow (57)Hip DXA BMD cross-sectional studiesChaganti 2010 \[[@CR30]\]Femoral neck BMD (C) DXAHip ROA Modified Croft score (categorical 0--4) (C)Age, BMI, height, activity level, race, 6-m walk pace, Nottingham muscle strength, inability to do chair stands, and clinic site,NRp \<0.0001+High (64)Higher BMD for higher grade of OA of hipAntoniades 2000 \[[@CR32]\]DXA BMD of the femoral neck of left (nondominant) hip with ROA (C)Radiographic OA (Croft score) (C)BMI, lifetime physical activity, menopausal status, use of oestrogen, and smokingOR 1.63, 95 % CI 1.06 to 2.50)OR 1.80, 95 % CI 1.05 to 3.12+ Association between BMD and hip ROA grade in the index hipHigh (64)Higher OA grade means higher BMD2D Hip bone shape longitudinal studiesAgricola 2013 \[[@CR146]\]Baseline 2D femoral and acetabular shape modes (segmented by statistical shape modelling) (C)THR at or within 5 years (L)Age, sex, BMI, shape modes5 modes were associated with THR OR 1.71 to 2.01, *p* ≤0.0013 modes were associated with THR OR 1.78 to 2.10, *p* ≤0.001+ Increasing femoral head asphericity is associated with THRHigh (72)Agricola 2013 \[[@CR147]\]Baseline alpha angle (2D femur shape) dichotomous abnormal \>60 °, normal ≤60 ° (C)Incident ROA hip (KL \>1), incident end-stage ROA hip (KL \>2 or THR) at or within 5 years (L)Age, sex, BMI, KL gradeOR (95 % CI) Incident ROA hip 6.82 (3.55 to 13.10) *p* \<0.0001OR (95 % CI) incident ROA hip 2.42 (1.15 to 5.06) *p* = 0.02, incident severe ROA or THR 3.67 (1.68 to 8.01) *p* \<0.0001+ Elevated alpha angle is associated with incident end-stage OA hipHigh (67)Agricola 2013 \[[@CR148]\]Baseline 2D centre edge angle (acetabular shape): 25 ° \<normal \<40 °, undercoverage \<25 °, overcoverage \>40 ° (C)Incidence within 5 years of: 1. ROA hip (KL \>1), 2. end-stage OA (KL \>2 or THR)Age, sex, BMI, KL gradeOR (95 % CI) overcoverage 0.52 (0.19 to 1.43) *p* = 0.21, undercoverage 3.64 (1.91 to 6.99) *p* = 0.00OR (95 % CI) overcoverage 0.34 (0.13 to 0.87) *p* = 0.025, undercoverage 5.45 (2.40 to 12.34) *p* = 0.00Overcoverage is protective against OA incidence (−). Undercoverage is associated with greater odds of OA incidence and end-stage OA (+)High (67)2D and 3D hip bone shape cross-sectional studiesGosvig 2010 \[[@CR149]\]Categorical hip 2D deformity: 1. normal, 2.'pistol grip', 3) deep acetabular socket (C)Presence of radiographic hip OA (JSW ≤2 mm) (C)Age, sex, BMI, other hip deformitiesNRRR (95 % CI) pistol grip 2.2 (1.7 to 2.8) *p* \<0.001, deep acetabular socket 2.4 (2.0 to 2.9) *p* \<0.001, normal (*p* \>0.05)+Low (50)Reichenbach 2011 \[[@CR27]\]The presence or absence of any 3D semi-quantitative MRI-defined cam-deformity (C)Combined femoral and acetabular cartilage thickness (C)Age, BMI (NB all participants were young men)Unadjusted mean cartilage thickness difference with CAM deformity −0.24 mm (95 % CI −0.46 to −0.03)Adjusted mean cartilage thickness difference with CAM deformity −0.19 mm (95 % CI −0.41 to 0.02)NCHigh (64)2D hip bone shape case control studiesDoherty 2008 \[[@CR43]\]Non-spherical femoral head 2D shape assessment: 1. appearance of 'pistol grip deformity' (C), 2. maximum femoral head diameter ratio to minimum parallel femoral neck diameter (C)Presence of radiographic hip OA (JSW ≤2.5 mm) (C)Age, sex, BMI, BMD, physical activity, history of hip injury, type 3 hand (index finger shorter than ring finger), hand nodes, and center-edge angleOR (95 % CI) pistol grip deformity 5.75 (4.00 to 8.27). Femoral head-to-neck ratio 10.45 (7.16 to 15.24)OR (95 % CI) pistol grip deformity 6.95 (4.64 to 10.41). Femoral head-to-neck ratio 12.08 (8.05 to 18.15)+Low (53)Barr 2012 \[[@CR150]\]2D Shape measures of centre-edge angle (acetabular shape) (C)THR vs no radiographic progression over 5 years (L)Age, gender, BMI KL grade, use of walking stick, WOMAC function, duration of painOR (95 % CI) mode 2 0.74 (0.50 to 1.10) *p* \>0.05OR (95 % CI) Mode 2 0.17 (0.04 to 0.71) p \<0.05NB, this model association is inverse and correlates with acetabular shapeHigh (76)Nicholls 2011 \[[@CR39]\]CAM deformity; mean modified triangular index height, alpha angle. 2D acetabular dysplasia; mean lateral center edge angle, (C)Total hip replacement (L)BMI, ageOR (*p* value) triangular index 1.131 (0.021). Alpha angle 1.056 (\<0.0005). Centre edge angle 0.906 (0.004)OR (*p* value) Triangular index 1.291 (0.011). Alpha angle 1.057 (\<0.0005). Centre- edge angle 0.887 (0.002)+ Association of hip replacement with CAM impingement and acetabular dysplasia indicated by these resultsHigh (71)Ankle scintigraphic subchondral bone cross-sectional studiesKraus 2013 \[[@CR60]\]Ipsilateral late phase bone scintigraphy, retention presence in tibiotalar joint (C)Tibiotalar ROA KL grade and JSN (C)Age, gender, BMINRKL grade *r* = 0.49, *p* \<0.0001. JSN *r* = 0.35, *p* \<0.0001+High (71)Knupp 2009 \[[@CR24]\]Late phase bone scintigraphy, semi-quantitative retention scoring of tibiotalar joint (C)Tibiotalar ankle joint JSN. (modified Takakura score) (C)Nil0.62 to 0.75 (*p* \<0.01)NR+Low (57)Positive correlation was reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−).*BMD* bone mineral density, *BML* bone marrow lesion, *C* a feature or outcome described in cross-section, *CT* computed tomography, *DXA* dual-energy x-ray absorptiometry, *HOAMS* Hip osteoarthritis MRI scoring system, *IPJ* interphalangeal joint, *JSN* joint space narrowing, *JSW* joint space width, *KL* Kellgren-Lawrence, *L* a feature or outcome described longitudinally, *NA* no association, *NC* no conclusion could be found for an association between bone feature and outcome measure, *MRI* magnetic resonance imaging, *PFJ* patellofemoral joint, *ROA* radiographic osteoarthritis, *OA* osteoarthritis, *OARSI* Osteoarthritis Research Society International, *OR* odds ratio, *RR* relative risk, *TFJ* tibiofemoral joint, *THR* total hip replacement, *TKR* total knee replacement, *VAS* visual analogue scale, *WOMAC* Western Ontario and McMaster Universities arthritis index, *WORMS* whole-organ magnetic resonance imaging score

### Bone marrow lesions {#Sec29}

MRI (one case series, two cross-sectional studies): one well-adjusted, high quality analysis of a prospective OA case series, found that increasing BML number and size in the interphalangeal joints at baseline conferred greater odds of structural progression of OA \[[@CR141]\]. Two adjusted cross-sectional analyses found increasing BML number and size scores were associated with increasing severity of structural progression \[[@CR142], [@CR143]\]. In summary, BMLs are independently associated with structural progression of hand OA.

### Osteophyte attrition and cysts {#Sec30}

One cross-sectional, adjusted analysis found greater MRI attrition or MRI osteophyte number and size was associated with greater structural severity \[[@CR142]\]. However, greater presence of cysts observed on MRI was not associated with greater structural severity of OA \[[@CR142]\]. In summary, osteophytes and attrition, but not cysts, are associated with structural severity of hand OA.

Relationship between hand bone feature and pain {#Sec31}
-----------------------------------------------

The association between bone features and pain is described in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}.Table 4Hand and hip pain associations by feature and quality scoreAuthorFeature (method)Pain outcomeAdjustment for confoundersAssociation (magnitude) crudeAssociation (magnitude) adjustedAssociationQuality score (%)Hand MRI bone marrow lesion case seriesHaugen 2014 Abstract \[[@CR144]\]Sum scores (0--48) for BMLs (Oslo hand OA MRI score) (C)AUSCAN pain scale (L)Age, sex, BMI, follow-up timeNR*β* = −0.26, 95 % CI −0.55 to 0.03NAHigh (61)Hand MRI bone marrow lesion cross-sectional studiesHaugen 2012 \[[@CR145]\]BML (Oslo MRI hand score) (C) IPJs sum scoresAUSCAN pain scale (C)Age, sexNROR (95 % CI) 0.96 (0.82 to 1.12)NAHigh (64)Hand MRI osteophyte cross-sectional studiesHaugen 2012 \[[@CR145]\]Osteophyte (Oslo MRI hand score) (C) IPJs sum scoresAUSCAN pain scale (C)Age, sexNROR (95 % CI) 1.04 (0.98 to 1.10)NAHigh (64)Hand MRI attrition cross-sectional studiesHaugen 2012 \[[@CR145]\]Attrition (Oslo MRI hand score) (C) IPJs sum scoresAUSCAN pain scale (C)Age, sexNROR (95 % CI) 1.15 (0.98 to 1.34)NAHigh (64)Hand MRI subchondral cyst cross-sectional studiesHaugen 2012 \[[@CR145]\]Cyst (Oslo MRI hand score) (C) IPJs sum scoresAUSCAN pain scale (C)Age, sexNROR (95 % CI) 0.93 (0.56 to 1.55)NAHigh (64)Hand scintigraphy subchondral bone cross-sectional studiesMacfarlane 1993 \[[@CR61]\]Late phase isotope bone scan small joints of the hand (C)Hand pain VAS (C)NilCorrelation coefficient 0.06, *p* = 0.304NRNALow (57)Hip MRI bone marrow lesion cross-sectional studiesKumar 2013 \[[@CR151]\]Total hip semi-quantitative BML score (C)Self-reported hip pain HOOS score (C)NilNRp correlation −0.29 (*p* \<0.01)A higher BML score means a lower or worse HOOS pain scoreHigh (71)Maksymowych 2014 \[[@CR152]\]Semi-quantitative BML HIP (HOAMS) (C)Baseline WOMAC pain (C)Nil*p* \<0.001NR+High (64)Hip MRI subchondral cyst cross-sectional studiesKumar 2013 \[[@CR151]\]Total hip semi-quantitative subchondral cyst score (C)Self-reported hip pain HOOS score (C)NilNRp correlation −0.37 (*p* \<0.001)A higher cyst score means a lower or worse HOOS pain scoreHigh (71)Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). *AUSCAN* Australian/Canadian Osteoarthritis hand index, *BML* bone marrow lesion, *C* a feature or outcome described in cross-section, *chronic pain* knee pain on most days for at least the last month, *HOAMS* Hip osteoarthritis MRI scoring system, *HOOS* Hip dysfunction and osteoarthritis outcome score, *IPJ* interphalangeal joint, *L* a feature or outcome described longitudinally, *NA* no association, *NR* not recorded, *OA* osteoarthritis, *OR* odds ratio, *VAS* visual analogue scaleTable 5The summary subchondral bone associations with joint replacement, structural progression and pain in peripheral OASubchondral bone feature of OAPain and structural associationsKnee structureKnee painHand structureHand painHip structureHip painAnkle structureMRI bone marrow lesionsProgression (i)LPS (i)Progression (i)No LPS (w)Severity (w)Severity (n)IFP (n)No severity (n)TKR (i)MRI osteophytesProgression (i)LPS (n)Severity (n)No severity (n)TKR (n)MRI bone attritionNo progression (0)No severity (0)Severity (n)No severity (n)MRI bone shape or dimensionsProgression (i)IFP (i)No severity (0)Severity (n)TKR (i)MRI bone cystNo progressionNo LPS (n)No severity (n)No severity (n)Severity (n)?severityMRI or CT trabecular morphometryProgression (n)Severity (n)DXA or CT Peri-articular BMDProgression (n)Severity (w)2D Bone shapeSeverity (w)Severity (n)Progression (i)THR (i)ScintigraphyNo Progression (0)No severity (n)Severity (w)*CT* computed tomography, dual-energy *DXA* x-ray absorptiometry, *(i)* independent association, *IFP* incident frequent pain, *(n)* association with no or inadequate covariate adjustment, *TKR* total knee replacement, *THR* total hip replacement, *LPS* mean change in longitudinal pain severity, *(w)* well-adjusted association, *(0)* association insignificant after covariate adjustment

### Bone marrow lesions {#Sec32}

MRI (one case series, one cross-sectional study): one well-adjusted, high quality analysis of a prospective OA case series, found that BML number and size at baseline was not associated with longitudinal change in hand pain \[[@CR144]\]. One adjusted cross-sectional analysis found no association of BMLs with severity of pain \[[@CR145]\]. In summary, BMLs are not independently associated with longitudinal or cross-sectional severity of pain.

### Osteophyte attrition and cysts {#Sec33}

One cross-sectional, adjusted analysis found no association between bone features, osteophytes, attrition or cysts observed on MRI, and pain severity \[[@CR145]\]. In summary, osteophytes, attrition and cysts are not associated with severity of hand pain.

### Scintigraphy {#Sec34}

Scintigraphy (one cross-sectional study): one cross-sectional unadjusted analysis found no significant association between bone signal in the hands and severity of pain. In summary, bone scintigraphy signal is not associated with severity of pain in hand OA.

Relationship between hip bone feature and structural progression {#Sec35}
----------------------------------------------------------------

The association between bone features, and structural progression and joint replacement is described in Tables [3](#Tab3){ref-type="table"} and [5](#Tab5){ref-type="table"}.

### Bone marrow lesions {#Sec36}

MRI (two cross-sectional studies): one well-adjusted \[[@CR69]\] and one unadjusted \[[@CR46]\] cross-sectional analysis both found that BMLs were associated with greater structural severity. In summary, BMLs are associated with structural severity of hip OA.

### Trabecular bone morphometry {#Sec37}

One unadjusted cross-sectional analysis found greater MRI bone volume fraction, trabecular thickening, trabecular number and lower trabecular spacing were associated with greater structural severity of OA \[[@CR33]\]. In summary, bone volume fraction, trabecular thickening, number and spacing are associated with structural severity in hip OA.

### Peri-articular bone mineral density {#Sec38}

DXA (two cross-sectional studies): one well-adjusted \[[@CR30]\] and one adjusted \[[@CR32]\] cross-sectional analysis found greater BMD was associated with greater structural severity. In summary, BMD is associated with structural severity of hip OA.

### 2D and 3D hip bone shape {#Sec39}

Hip bone shape (three cohort, two cross-sectional, three case--control studies): in two prospective cohort, well-adjusted, high quality analyses increasing asphericity of the femoral head (measured as an elevated alpha angle, or in shape modes 11 and 15) was associated with total hip replacement (THR) \[[@CR146]\] or with structural progression and THR \[[@CR147]\] respectively. In one prospective cohort, well-adjusted, high quality analysis, acetabular undercoverage of the femoral head (a low centre-edge angle) was associated with structural progression or THR \[[@CR148]\]. In one well-adjusted cross-sectional analysis, 2D asphericity deformity of the femoral head (cam-type deformity) was associated with structural severity \[[@CR149]\]. In one well-adjusted cross-sectional analysis of MRI-determined femoral head asphericity in asymptomatic young men, there was a significantly lower cartilage thickness in those with than those without any detectable asphericity. This became insignificant after covariate adjustment \[[@CR27]\]. Case--control analyses identified the same associations as the cohort analyses \[[@CR39], [@CR43], [@CR150]\]. In summary, asphericity of the femoral head and acetabular undercoverage of the femoral head are independently associated with structural progression and THR.

Relationship between hip bone feature and pain {#Sec40}
----------------------------------------------

The association between bone features and pain is described in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}.

### Bone marrow lesions {#Sec41}

MRI (two cross-sectional studies): two cross-sectional, unadjusted analyses found that increasing semi-quantitative BML scores were associated with greater severity of pain \[[@CR151], [@CR152]\]. In summary, BMLs are associated with severity of pain in hip OA.

### Bone cyst {#Sec42}

One cross-sectional, unadjusted analysis found that increasing semi-quantitative cyst scores on MRI were associated with greater severity of pain \[[@CR151]\]. In summary: cysts are associated with severity of pain in hip OA.

Relationship between ankle bone features and structural progression {#Sec43}
-------------------------------------------------------------------

The association between bone features and structure is described in Table [3](#Tab3){ref-type="table"} and [5](#Tab5){ref-type="table"}.

### Scintigraphy {#Sec44}

Scintigraphy (two cross-sectional studies): one well-adjusted \[[@CR59]\] and one unadjusted \[[@CR62]\] cross-sectional analysis found the presence or semi-quantitative scoring of late-phase bone signal in the tibiotalar joint was associated with greater structural severity. In summary, bone scintigraphy signal is associated with ankle structural severity.

Discussion {#Sec45}
==========

This systematic review is the first to have incorporated quality scoring alongside statistical adjustment in the comprehensive examination of the relationship of subchondral bone pathology with both structural progression of OA and pain for all non-conventional types of radiographic imaging of peripheral joints with OA. This systematic review has concluded that there are independent associations between imaging-assessed bone pathology and structural progression and pain in the knee, hand, and hip.

Subchondral bone pathology may lead to cartilage degeneration by altering the biomechanical force distribution across joint cartilage, or disruption of the osteochondral junction and release of soluble biomediators influencing the cartilage \[[@CR153], [@CR154]\]. In OA the homeostatic process of subchondral bone remodeling fails, leading to increased bone turnover, volume and change in stiffness and shock-absorbing capacity \[[@CR155]--[@CR157]\]. BMLs histologically represent increased bone turnover \[[@CR158]\]. Cartilage overlying altered bone has been observed to have greater damage than healthy bone in knees from human cadavers \[[@CR159]\]. That study, and an excluded study \[[@CR160]\], concur with the independent association between BMLs, and structural progression of OA in knees and hands and total knee replacement, as concluded by this analysis. Although randomised control trials were not excluded from this review, several such trials were excluded on the basis of failure to formally quantify any correlation between BMLs and structural progression outcomes. These include the strontium \[[@CR161]\], intensive weight-loss therapy \[[@CR162]\] and glucosamine \[[@CR163]\] trials, and some of these describe a concordant reduction in BML size and cartilage volume loss.

Osteophytes represent subchondral bone hypertrophy typical of OA. They represent endochondral and direct bone formation and create a circumferential increase in bone area around each knee cartilage plate, particularly on the medial side in OA \[[@CR118]\], which concurs with the independent association between osteophytes demonstrated on MRI and structural progression as observed in this analysis.

In terms of bone morphology, knee OA is associated with shallow trochlear patellar grooves in multiple epiphyseal dysplasia \[[@CR164]\]. These findings concur with the findings of Stefanik and Kalichman, and colleagues in studies of knee OA in this review \[[@CR115], [@CR116], [@CR165]\]. Anterior-cruciate ligament (ACL) rupture represents a risk factor for developing knee OA. In cases of ACL tear in previously normal knees of young healthy adults, the 3D shape of the femur, tibia and patella expands more rapidly than in controls without radiographic evidence of knee OA in the subsequent 5 years \[[@CR166]\]. The 3D shape of the same knee bones has also been associated with the outcome of joint replacement \[[@CR167]\]. This highlights the importance of bone shape and concurs with our conclusion that 3D knee shape and 2D hip shape are independently associated with structural progression of OA and total joint replacement.

We found that bone attrition and cysts were associated with structural progression or severity, but not after covariate adjustment, which included other OA subchondral bone features. This suggests these bone features are an epiphenomenon of the pathogenic process of structural progression rather than a primary cause. This hypothesis is supported by bone cysts and attrition frequently occurring synchronously with BMLs \[[@CR88], [@CR138]\] and incident bone attrition has been strongly associated with the presence of BMLs within the same compartment \[[@CR168]\].

Increasing bone volume fraction, trabecular number and thickness, but decreasing trabecular spacing on CT and MRI studies were associated with structural progression. These specific associations concur with numerous histological analyses of peripheral joint OA \[[@CR169]--[@CR171]\].

Subchondral bone, particularly BMLs, have been found to be associated with pain in knee, hip and hand OA. However, some analyses, in which pain was measured using heterogenous pain outcomes, report an absence of longitudinal or cross-sectional association with BMLs \[[@CR101], [@CR172], [@CR173]\]. Furthermore, previous systematic reviews have concluded moderate association at the most between BMLs and knee pain \[[@CR7], [@CR14]\]. With the benefit of incorporating more well-adjusted analyses in this systematic review, we have highlighted that BMLs are independently longitudinally associated with change in severity of pain, but are only associated with incident frequent knee pain. In analyses excluded from the current review, incident knee BMLs predicted incident knee pain in healthy community-based adults at risk of OA \[[@CR174]\]. Concurrent trends in reduction of pain and BML size were observed in the zoledronic acid trial \[[@CR175]\] and the intensive diet and exercise for arthritis trial \[[@CR176]\]. These were not included because they did not make a formal comparison of pain and BMLs. The mechanism by which BMLs may cause pain is unknown but may include subchondral microfractures, angina from a decreased blood supply causing ischaemia, and raised intraosseous pressure \[[@CR177]--[@CR179]\].

The independent association between a mismatch of the femoral and tibial articulating surface areas and incident frequent knee symptoms indicates that bone shape may predict not only the incidence of radiographic knee OA \[[@CR120]\], but also symptomatic OA.

In terms of limitations, stratifying observational studies by quality may artificially create relatively high quality studies from a collection of generally low quality studies. However the distribution and summary statistics of quality scores indicate a suitably broad range of quality, particularly in the influential cohort studies with a mean of 54 % and range of 22−83 %. The decision to exclude articles reporting analysis of association that included fewer than 20 patients with OA may seem arbitrary. However, several papers report associations with the presence or absence of pain or structural progression based upon small numbers of patients. Our threshold decision reflects the absence of specific guidelines on how to exclude such papers, with inherent risk of imprecision, in the context of heterogenous populations and statistical analyses. Had these papers been included there would have been no change in any of the conclusions in Table [5](#Tab5){ref-type="table"} (data not shown). The use of joint replacement as an outcome measure has a number of limitations including the effect of patient willingness, variation in orthopaedic opinion, availability of health services and health insurance, and therefore may be influenced depending upon the country and context in which the study is performed.

Publication bias could not be assessed with a funnel plot as there were insufficient results for odds and relative risk ratios. The heterogenous nature of the measures of bone features and structural or pain outcomes precluded a meta-analysis or calculation of an effect size. This was because there were insufficient analyses describing the same association between the same bone features and outcome measure pair.

Conclusions {#Sec46}
===========

In conclusion subchondral bone plays an integral role in the pathogenesis of OA. BMLs, osteophytes identified on MRI and tibial bone area are independently associated with structural progression of knee OA. BMLs and tibial bone area are independently associated with TKR. BMLs are independently associated with structural progression of hand OA and 2D hip bone shape is associated with progression of structural hip OA and THR. BMLs are independently associated with longitudinal change in severity of pain and femorotibial articulating area mismatch is independently associated with incident frequent knee pain. These bone features may be used in the future for targeting treatment, stratifying patients into those most in need of OA modification and measuring treatment response.
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2D

:   two-dimensional

3D

:   three-dimensional

ACL

:   anterior cruciate ligament

BLOKS

:   Boston--Leeds osteoarthritis knee score

BMD

:   bone mineral density

BMI

:   body mass index

BML

:   bone marrow lesion

BOKS

:   Boston osteoarthritis of the knee study

BVF

:   bone volume fraction

Cam

:   a resemblance to a camshaft

CRP

:   C-reactive protein

CT

:   computed tomography

DMOAD

:   disease-modifying osteoarthritis drug

DXA

:   dual-energy x-ray absorptiometry

EMBASE

:   Excerpta Medica database

GARP

:   Genetics, osteoarthritis and progression study

HOAMS

:   Hip osteoarthritis MRI scoring system

IPJ

:   interphalangeal joint

JSN

:   joint space narrowing

JSW

:   joint space width

KL

:   Kellgren-Lawrence

KOSS

:   knee osteoarthritis scoring system

MOST

:   multicentre osteoarthritis study

MRI

:   magnetic resonance imaging

NA

:   no association

NC

:   no conclusion

OA

:   osteoarthritis

OAI

:   Osteoarthritis Initiative

OARSI

:   Osteoarthritis Research Society International

OR

:   odds ratio

PET

:   positron emission tomography

PFJ

:   patellofemoral joint

PRISMA

:   Preferred reporting items for systematic reviews and meta-analyses

qCT

:   quantitative computed tomography

ROA

:   radiographic osteoarthritis

RR

:   relative risk ratio

SSR

:   subchondral surface ratio

THR

:   total hip replacement

TFJ

:   tibiofemoral joint

TKR

:   total knee replacement

VAS

:   visual analogue scale

WOMAC

:   Western Ontario and McMaster Universities arthritis index

WORMS

:   whole-organ magnetic resonance imaging score
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